Stockwinners Market Radar for August 14, 2017 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

UAA UA

Hot Stocks

20:42 EDT Under Armour CEO Plank steps down from Trump's council - Under Armour (UAA, UA) CEO Kevin Plank said in a statement, "I joined the American Manufacturing Council because I believed it was important for Under Armour to have an active seat at the table and represent our industry. We remain resolute in our potential and ability to improve American manufacturing. However, Under Armour engages in innovation and sports, not politics. I am appreciative of the opportunity to have served, but have decided to step down from the council. I love our country and our company and will continue to focus my efforts on inspiring every person that they can do anything through the power of sport which promotes unity, diversity and inclusion."
MRK

Hot Stocks

18:27 EDT Trump: Merck a leader in higher drug prices, 'taking jobs out of the U.S.' - President Donald Trump tweeted, "@Merck Pharma is a leader in higher & higher drug prices while at the same time taking jobs out of the U.S. Bring jobs back & LOWER PRICES!" Reference Link
ALJJ

Hot Stocks

18:09 EDT ALJ Regional names Brian Hartman as CFO - ALJ Regional announced that it appointed Brian Hartman as its new CFO, responsible for overseeing all finance functions, replacing Rob Christ effective August 8. At the same time, ALJ also announced the appointment of Rob Christ as the CFO for its subsidiary, Carpets N' More. Christ's new appointment was also effective August 8.
CRDS

Hot Stocks

18:02 EDT Crossroads Systems files Chapter 11 case, prepackaged plan of reorganization - Crossroads Systems announced that it has filed a case under Chapter 11 of the Bankruptcy Code and a prepackaged Chapter 11 plan of reorganization that has been accepted by the holders of more than 2/3 of the Preferred Shares of CRDS. In connection with the filing, the company entered into restructuring support agreements with 210/CRDS Investment LLC and with certain holders of the company's Series F Preferred Stock. Subject to the terms and conditions of the Plan and the restructuring support agreement with 210, Dallas-based 210 will invest $4M cash in Crossroads Systems in exchange for shares of the reorganized company's common stock representing approximately 49.49% of the common stock of the reorganized company. In addition, 210 will provide up to $10M of financing for the company to use to implement its strategy of monetizing its intellectual property assets and pursuing investments in companies that generate profit and positive cash flows, thus creating long-term shareholder value. The Plan provides for the payment of all creditor claims in full, for holders of Preferred Shares to receive their pro rata share of $2,672,233.78 in cash plus 8% of the common stock of the reorganized company, and for holders of common stock to exchange their existing shares of common stock for an equivalent number of new shares of the common stock of the reorganized company, which shares would constitute approximately 42.51% of the outstanding share of the common stock of the reorganized company.
CE

Hot Stocks

18:01 EDT Celanese announces vinyl acetate monomer price increases - Celanese Corporation will increase list and off-list selling prices for vinyl acetate monomer to RMB200 per MT in China and $50 per MT in Asia outside China. The price increases below will be effective immediately, or as contracts otherwise allow, and are incremental to any previously announced price increases.
VST...

Hot Stocks

18:01 EDT Paulson & Co. increases stake in Valeant, exits Akorn, eBay - John Paulson's Paulson & Co. disclosed in an SEC filing its holdings as of June 30. Paulson's new buys during the second quarter included, by size of position, Vistra Energy Corp (VST), VWR Corp (VWR), Horizon Pharma (HZNP), Xcerra Corp (XCRA), and New Relic (NEWR). Paulson exits during the quarter included, by size of previous position, Akorn (AKRX), eBay (EBAY), Pfizer (PFE), Fidelity & Guaranty Life (FGL), and Etsy (ETSY). Paulson increased its stakes in Valeant Pharmaceuticals (VRX), T-Mobile US (TMUS), DISH Network (DISH), Monsanto (MON), and NXP Semiconductors (NXPI). Paulson reduced its stakes in Teva Pharmaceutical Industries (TEVA), Shire (SHPG), Mylan (MYL), Allergan (AGN), and Oasis Petroleum (OAS).
ATUS...

Hot Stocks

17:48 EDT Soros takes new stakes in Altice, General Mills, Kellogg - George Soros' Soros Fund Management disclosed in an SEC filing its holdings as of June 30. Soros' 80 new buys during the second quarter included, by size of position, Altice (ATUS), General Mills (GIS), Kellogg (K), and Plains GP Holdings (PAGP). Soros exited 143 positions during the quarter, including by size of previous position, Adecoagro (AGRO), Hewlett Packard Enterprise (HPE), and Symantec (SYMC). Soros increased its stake in 34 holdings, including by size of previous position, Viavi (VIAV), MakeMyTrip (MMYT), Kraft Heinz (KHC), Edgewell Personal Care (EPC), and Alibaba (BABA). Soros reduced its stake in 39 holdings, including by size of previous position, Lam Research (LRCX), Williams Cos (WMB), T-Mobile (TMUS), California Resources Corp (CRC), and Facebook (FB). Soros' top holdings as of June 30, in order of size, were Liberty Broadband (LBRDA), Caesars Acquisition (CACQ), TiVo (TIVO), Facebook, and Churchill Downs (CHDN).
FATE...

Hot Stocks

17:41 EDT On The Fly: After Hours Movers - UP AFTER EARNINGS: Fate Therapeutics (FATE), up 16.2%... Extreme Networks (EXTR), up 10.1%... Westport Fuel Systems (WPRT), up 7.3%. ALSO HIGHER: Synchrony Financial (SYF), up 4.6% after Berkshire Hathaway (BRK.A) took a new stake in the company... Pandora (P), up 4.2% after it named Roger Lynch as its new chief executive officer. DOWN AFTER EARNINGS: Photronics (PLAB), down 16.2%... Hollysys (HOLI), down 7.9%... Reata Pharmaceuticals (RETA), down 1.6%. ALSO LOWER: Omeros (OMER), down 5.9% after it filed to sell 3M shares of common stock... Genpact (G), down 2% after it filed to sell 10M shares of common stock for holders.
CELG

Hot Stocks

17:40 EDT Celgene director Ernest Mario sells 18.5K shares of company stock - Ernest Mario, a director at Celgene, disclosed in a filing after the close on Monday, that he'd sold 18,506 shares of company stock at an average price of $130.52 per share on August 10 for a total transaction value of $2,415,403.
CRDS

Hot Stocks

17:33 EDT Nasdaq determines Crossroads Systems stock to be delisted - According to a regulatory filing, on August 14, 2017, Crossroads Systems received a letter from The NASDAQ Stock Market stating that in accordance with Nasdaq Listing Rules 5101, 5110b and IM-5101-1, Nasdaq has determined that the company's common stock will be delisted from Nasdaq. The Notice further stated that unless the company requests an appeal of Nasdaq's determination, trading of the company's common stock will be suspended at the opening of business on August 23, 2017, and a Form 25-NSE will be filed with the Securities and Exchange Commission, which will remove the company's securities from listing and registration on Nasdaq. The company does not intend to request an appeal.
IEP...

Hot Stocks

17:30 EDT Icahn reduces stakes in PayPal, AIG, and Xerox - Carl Icahn's Icahn Capital disclosed in an SEC filing its holdings as of June 30. Icahn increased its stake in two holdings during the second quarter, including by size of previous position, Icahn Enterprises (IEP) and Freeport-McMoRan (FCX). Icahn reduced its stake in three holdings, including by size of previous position, PayPal (PYPL), American International Group (AIG), and Xerox (XRX). Icahn's top holdings as of June 30, in order of size, were Icahn Enterprises, American International Group, Herbalife (HLF), Cheniere Energy (LNG), and CVR Energy (CVI).
COST TIF

Hot Stocks

17:29 EDT Costco attributes ruling in Tiffany case to 'multiple errors' in trial procedure - Costco (COST) announced its response to the ruling in the case brought by Tiffany (TIF). Costco respectfully submits that the ruling is a product of multiple errors in pretrial, trial, and post-trial rulings and intends to appeal. As previously reported, the district court determined in 2015 that Costco had committed trademark counterfeiting when Costco displayed solitaire diamond rings in its membership warehouses next to signage that included the word "Tiffany" not combined with an immediately following modifier such as "setting," "set," or "style." Costco attempted to appeal this ruling prior to trial; Tiffany & Co. opposed the appeal, and the appellate court declined to exercise jurisdiction at that time. Thereafter, the district court held a jury trial and instructed the jury that the Court had already "found" that Costco's use of "Tiffany signage in the way I have described was willful and constituted counterfeiting of the Tiffany mark." Based on this instruction, as previously reported, in October 2016 the jury returned a verdict identifying amounts of profits earned on certain ring sales, statutory damages and punitive damages. The rings in question were not stamped or otherwise marked with the Tiffany & Co. name ; they were sold in plain beige and brown wooden boxes; they were accompanied by appraisal documents that did not mention Tiffany & Co., and with sales receipts that did not say Tiffany or Tiffany & Co. Notably, Tiffany & Co. did not claim in the lawsuit that it lost a single sale to Costco as a result of any sign. From a purchaser list of approximately 2,500, Tiffany identified fewer than 10 who said that they had misunderstood Costco's signage. This was not a case about counterfeiting in the common understanding of that word - Costco was not selling imitation Tiffany & Co. rings.
BABA...

Hot Stocks

17:23 EDT Appaloosa buys Alibaba stake, increases Google, Facebook, Apple stakes - David Tepper's Appaloosa Management disclosed in an SEC filing its holdings as of June 30. Appaloosa's 22 new buys during the second quarter included, by size of position, Alibaba (BABA), Dollar General (DG), and Stryker (SYK). Appaloosa exited 17 positions during the quarter, including by size of previous position, Regions Financial (RF), Pfizer (PFE), Mylan (MYL), Teva (TEVA), and Symantec (SYMC). Appaloosa increased its stake in 12 holdings, including by size of previous position, Micron (MU), Alphabet (GOOG), Western Digital (WDC), Facebook (FB), and Apple (AAPL). Appaloosa reduced its stake in 20 holdings, including by size of previous position, Southwest Air (LUV), General Motors (GM), Allergan (AGN), Kinder Morgan (KMI), and Williams Partners (WPZ). Appaloosa's top holdings as of June 30, in order of size, were Allergan, Alphabet, Alibaba, Micron, and Williams Partners.
HZNP

Hot Stocks

17:23 EDT Paulson & Co. reports new 4.94M share stake in Horizon Pharma
AMRK

Hot Stocks

17:21 EDT A-Mark Precious Metals acquires the assets of Goldline International - A-Mark Precious Metals has entered into an agreement to acquire substantially all of the assets of Los Angeles-based Goldline A-Mark Precious Metals highlighted the acquisition summary and benefits: "Asset purchase for net consideration of approximately $6.4M over net tangible asset value; Adds a longstanding client base of more than 150,000 precious metal and numismatic clients Expands client pipeline by adding 1.2 million client leads Bolsters A-Mark's distribution by adding an expansive direct-to-client distribution model Enhances A-Mark's marketing and technology capabilities, including access to an analytics system to better understand client data and buying behaviors For nearly six decades, Goldline has delivered world-renowned gold, silver and platinum coins and bars to collectors and investors globally. Since 2000, Goldline has distributed more than $4 billion of precious metals through its various channels, including TV, radio and online platforms. The company has established a reputation in the industry for its best-in-class client service and support. Under the terms of the agreement, A-Mark will acquire substantially all of Goldline's assets, including client lists, prospect leads and storage clients. The net consideration for the assets is approximately $6.4 million over net tangible asset value, payable in cash at the closing. A-Mark will finance the acquisition primarily through the proceeds of a three-year privately placed credit facility, to be entered into by the wholly owned subsidiary of A-Mark, which will hold the Goldline assets following the acquisition. "
MIC

Hot Stocks

17:16 EDT Macquarie Infrastructure unit to acquire Orion Jet Center, terms not disclosed - Macquarie Infrastructure Corporation announced that its Atlantic Aviation subsidiary has entered into an agreement to purchase the assets of Orion Jet Center at Miami-Opa Locka Executive airport. The acquisition increases the Atlantic Aviation network of fixed base operations to 71 locations throughout the US. Terms of the transaction were not disclosed. Closing of the transaction is expected in the third quarter of 2017, subject to satisfaction of conditions including receipt of relevant government and regulatory approvals.
CGIX

Hot Stocks

17:08 EDT Cancer Genetics sees vivoPharm acquisition immediately accretive - Cancer Genetics and vivoPharm announced they have entered into a definitive agreement for Cancer Genetics to acquire vivoPharm for approximately $12M This transaction will significantly strengthen CGI's position as a premier leader for oncology discovery, in vivo and in vitro drug development and early phase clinical trial testing for biotechnology and pharmaceutical companies. With over a decade of experience in delivering a wide range of discovery and preclinical services to support drug development, target validation and biomarker analysis, vivoPharm has supported over 200 IND submissions for innovative therapies, with a significant focus on immuno-oncology. "This accretive acquisition immediately strengthens our market position as the premier partner for oncology therapeutic and diagnostic development while furthering our mission to change patient outcomes and improve industry insight into the mechanisms of oncology," said Mr. Panna Sharma, President and CEO of Cancer Genetics, Inc. "Partnering with biotechnology and pharmaceutical companies to continue advancing our market share in oncology testing and diagnostics has been a proven approach in the development of CGI. vivoPharm furthers our biopharma strategy and adds capabilities to enable our strategy to rescue and repurpose oncology drugs while providing us enhanced, revenue-generating capabilities across a broad and globally diverse client base." The purchase price is approximately $12M, which will include $1.2M in cash and the remaining 90% will be shares of CGI common stock based on the volume weighted average price over the last 20 business days. The transaction has been approved by the Boards of Directors of both companies. Additionally on August 14, CGI entered into an equity financing arrangement for up to USD $16M to fund the acquisition, and increase working capital for general corporate purposes. The initial tranche of funding will be $3M, and additional tranches can be accessed by CGI at the company's discretion over the next 2 years.The acquisition is expected to be immediately accretive, adding both revenue and income. The combination of capabilities is expected to create considerable business opportunities in both pre-clinical studies and immuno-oncology clinical trials, to further accelerate CGI's strategy to be the premier partner of choice for oncology innovation and development from bench to bedside.
IAG

Hot Stocks

17:07 EDT IAMGold acquires 27.7M common shares of TomaGold Corporation - IAMGold announces that it has acquired 27,777,777 common share of TomaGold Corporation. IAMGOLD subscribed for 27,777,777 Common Shares of TomaGold from treasury, representing approximately 19.98% of the outstanding Common Shares of TomaGold. The Common Shares were purchased at a price of $0.09 per Common Share, for an aggregate purchase price of $2.5M. Prior to the Acquisition, IAMGOLD did not hold any Common Shares of TomaGold. IAMGOLD has not acquired the Common Shares with an intention to acquire control of TomaGold. IAMGOLD will monitor the business, prospects, financial condition and potential capital requirements of TomaGold. Depending on its evaluation of these and other factors, IAMGOLD may from time to time in the future increase or decrease its ownership, control or direction over Common Shares or other securities of TomaGold through market transactions, private agreements, subscriptions from treasury or otherwise.
CGIX

Hot Stocks

17:03 EDT Cancer Genetics announces 'transformative,' 'accretive' purchase of vivoPharm
NEWR

Hot Stocks

16:59 EDT Eminence Capital reports 5.5% passive stake in New Relic
MRCY

Hot Stocks

16:57 EDT Mercury Systems receives $4.3M order for radar subsystems - Mercury Systems announced it received a $4.3M follow-on order from a leading defense prime contractor to provide radar subsystems and related digital processing technologies for a missile defense application. The order was booked in the Company's fiscal 2017 fourth quarter. The radar signal processing subsystem is based on an open systems architecture using heterogeneous processors, the Linux operating system, and the Message Passing Interface API. The subsystem performs all the signal processing functions including beamforming, pulse compression, Doppler processing, and target detection. "We are extremely pleased to continue our relationship with this longstanding customer," said Didier Thibaud, Mercury's Executive Vice President and Chief Operating Officer. "Mercury's commitment to providing the most advanced and reliable signal processing systems and architecture has ensured our continued participation in this mission-critical defense program."
HPE...

Hot Stocks

16:56 EDT Greenlight take new stake in HP Enterprise, exits stake in Time Warner - David Einhorn's Greenlight Capital disclosed in an SEC filing its holdings as of June 30. Greenlight's six new buys during the second quarter included, by size of position, HP Enterprise (HPE), TEGNA (TGNA), Adient (ADNT), Tempur Sealy (TPX), and Cars.com (CARS). Greenlight exited nine positions during the quarter, including by size of previous position, Time Warner (TWX), Syngenta (SYT), Cigna (CI), IAC/InterActiveCorp (IAC), and Alere (ALR). Greenlight increased its stake in five holdings, including by size of previous position, Perrigo (PRGO), Mylan (MYL), Dillard's (DDS), Micron (MU), and DSW (DSW). Greenlight reduced its stake in six holdings, including by size of previous position, Chemours (CC), PVH Corp (PVH), Fred's (FRED), Quorum (QHC), and Apple (AAPL). Greenlight's top holdings as of June 30, in order of size, were General Motors (GM), AerCap (AER), Apple, Mylan, and CONSOL Energy (CNX).
SRC

Hot Stocks

16:56 EDT Spirit Realty announces new $250M stock repurchase program - Spirit Realty Capital announced that its Board of Directors has authorized a new stock repurchase program for up to $250M of its common stock to be undertaken within 18 months from the date of authorization.
CVNA

Hot Stocks

16:50 EDT Melvin Capital reports 5.6% passive stake in Carvana
CARS

Hot Stocks

16:49 EDT Southpoint Capital reports 5.2% passive stake in Cars.com
GBL EDGW

Hot Stocks

16:49 EDT Gabelli reports 15.29% stake in Edgewater
INTC YTRA

Hot Stocks

16:45 EDT Intel reports 9.1% passive stake in Yatra
SYF...

Hot Stocks

16:39 EDT Berkshire Hathaway takes new stakes in Synchrony, STOR Capital - Berkshire Hathaway disclosed in an SEC filing its holdings as of June 30. Berkshire Hathaway's two new buys during the second quarter included, by size of position, Synchrony (SYF) and STORE Capital (STOR). Berkshire Hathaway exited one position during the quarter, GE (GE). Berkshire Hathaway increased its stake in five holdings, including by size of previous position, BNY Mellon (BK), General Motors (GM), and Apple (AAPL). Berkshire Hathaway reduced its stake in seven holdings, including by size of previous position, IBM (IBM), Wells Fargo (WFC), WABCO Holdings (WBC), Sirius XM (SIRI), and United Continental (UAL). Berkshire Hathaway's top holdings as of June 30, in order of size, were Kraft Heinz (KHC), Wells Fargo, Apple, Coca-Cola (KO), and American Express (AXP).
KNL

Hot Stocks

16:38 EDT Knoll names Charles Rayfield CFO - Knoll has named Charles Rayfield its new SVP and CFO, effective August 14.Rayfield joined Knoll in 2015 as the Company's Vice President, Finance and Corporate Controller; since June of this year, he has also served as the company's Chief Accounting Officer and Acting Principal Financial Officer.
NRIM

Hot Stocks

16:36 EDT Northrim BanCorp to sell Northrim Benefits Group to Acrisure - Northrim BanCorp Inc., the parent company of Northrim Bank announced that Northrim Benefits Group, NBG, sold substantially all of its assets to Michigan-based Acrisure. Acrisure, a national insurance brokerage company offering insurance and risk management services, is the 12th largest insurance agency in the United States with more than 120 affiliated agencies. NBG will be Acrisure's second affiliate agency in Alaska."We purchased our ownership in Northrim Benefits Group in 2005 to provide additional financial services to our growing customer base," said Joe Schierhorn, President and CEO of Northrim BanCorp. "Today, we believe there are benefits for Northrim Benefits Group to align with Acrisure, as the health insurance industry continues to evolve. We believe that our customers have benefited from Northrim's relationship with this complementary business services group, and NBG has been a solid contributor to revenues." Northrim is selling its interest in NBG's assets for $4.6 million, generating a net profit after tax of $2.7M, or 39c per share, in the third quarter of 2017. In 2016, NBG contributed $3.8M, or 3.8% of Northrim's total revenues. Current management and staff of NBG will remain in place following the transaction, which closed on August 14. "We are excited to affiliate with Acrisure to provide even more insurance products and services to our customers," said Joshua Weinstein, President of NBG.
FTFT

Hot Stocks

16:33 EDT Future FinTech to delay filing of Form 10-Q - Future FinTech announced it will be delaying the filing of its Quarterly Report on Form 10-Q for the quarter ended June 30, 2017. The Company has filed an extension with the SEC in accordance with Rules 12b-25(b) and 12b-25(c) for the Form 10-Q and anticipates filing the Form 10-Q before the fifth calendar day following the prescribed due date.
PLAB

Hot Stocks

16:30 EDT Photronics trading resumes
OCX

Hot Stocks

16:24 EDT OncoCyte confirms launch plans for lung cancer diagnostic test - OncoCyte reported the following developments: Financial results for the quarter ended June 30, Planned expansion of the senior management team by adding a Vice President of Sales and full time CFO, Branding for its lung cancer diagnostic test, and Progress toward CLIA lab licensing.OncoCyte announced that it is planning to expand its senior management team. The company is now in the final stages of hiring a Vice President of Sales. If hired, this individual will bring many years of sales and marketing leadership within the healthcare industry at leading diagnostic companies. In addition, OncoCyte has begun the process of hiring a full time CFO. The company has selected the name DetermaVu for its lung cancer test, a name that directly speaks to how the test will assist clinicians in determining the next steps for their patients by providing information that is not available by using only the current standard of care, a low-dose CT scan. OncoCyte also announced that its clinical laboratory has passed the required review and inspection by the California Department of Public Health Laboratory Field Services for State Clinical Laboratory licensing and CLIA certification. OncoCyte expects to receive its California State Clinical Laboratory license and CLIA Certificate in the coming weeks. "Our team has established a solid track record of achieving important milestones and, as a result of recent progress, we are continuing to plan for the commercial launch of our lung cancer diagnostic test in the fourth quarter of 2017," said William Annett, Chief Executive Officer. "Upon launch, DetermaVu will be the only commercially available non-invasive liquid biopsy confirmatory lung cancer diagnostic test in what we estimate could be a $4.7B annual market in the U.S. depending on market penetration and reimbursable pricing."
CTO

Hot Stocks

16:23 EDT Consolidated Tomoka agrees to amendment to Minto Communities sale - Consolidated-Tomoka Land announced that the Company and Minto Communities have agreed to an amendment to the contract for the sale of land to Minto Communities. The Amended Minto II Contract reduced the acres of land being sold to 1,614 acres for a reduced purchase price of $26.5M, which equates to a price per acre of approximately $16,400. The reduced acreage reflects the removal of certain acres the Company determined to retain to benefit certain other of its land parcels. The reduced price per acre reflects the impact of the resolution of the EPA matter regarding the wetlands impacts on the acreage covered by the original contract with Minto which, as a result, reduced the amount of useable acreage and the efficiency of the original design of Minto's development thereby lowering Minto's yield of buildable home sites and adversely impacting certain development costs associated with roadwork and similar design elements. Minto intends to utilize the Second Parcel for the second phase of their active adult community Latitude Margaritaville. The Amended Minto II Contract also accelerated the potential closing date to no later than December 14, 2018 based upon Minto obtaining the necessary development approvals and acknowledges that Minto's inspection period has concluded. Pursuant to the Amended Minto II Contract, Minto has committed to spend a minimum of $300,000 for the purpose of obtaining the aforementioned development approvals.
SABR

Hot Stocks

16:18 EDT Sabre names Vish Saoji as Chief Technology Officer - Sabre announced that it has named Vish Saoji as chief technology officer, effective September 5. Saoji will join Sabre from GE Healthcare Digital, where he serves as CTO for Software Engineering and is responsible for a global team tasked with technology engineering, product portfolio and cloud platform strategies.
DISH P

Hot Stocks

16:18 EDT DISH to shift Sling TV leadership into Erik Carlson's portfolio - DISH Network (DISH) announced that it will shift the leadership of its over-the-top service, Sling TV, into DISH President and Chief Operating Officer Erik Carlson's portfolio. The move comes with the news that outgoing Sling TV CEO, Roger Lynch, will join Pandora (P) as CEO. Management changes for Sling TV are effective Aug. 31. "Erik is positioned to fully support and grow our enterprise's portfolio, including our Sling TV asset, as we work to connect 100 percent of the country through satellite, OTT, wireless and even digital over-the-air offerings," said Charlie Ergen, DISH Chairman and CEO. "Our company has built incredible assets from satellite, broadband, and streaming technologies, to a fleet of in-home experts and software development. We will continue to leverage those assets to be tuned in to the needs of our customers."
LDOS

Hot Stocks

16:17 EDT Leidos, Biosortia Pharmaceuticals execute Memorandum of Understanding - Leidos has signed a Memorandum of Understanding with Biosortia Pharmaceuticals to explore creating a new business relationship with a focus on identifying and advancing immuno-oncology and other immunotherapeutic opportunities. Both companies offer existing and future assets in the immunotherapeutic space that will enable them to deliver de-risked assets to a future pharmaceutical partner for development. The companies' assets include compounds derived from microbiome sources, screening assays, and scientific expertise that will focus on moving assets to investigational new drug clinical research for development by the partner. Technologies involved include Biosortia's proprietary microbiome harvesting and mining capabilities and Leidos' big data analytics. Leidos has advanced various immune checkpoint inhibitor peptides that provide unique differentiation from the current therapeutic monoclonal antibodies. When coupled with Leidos' data analytics technologies and capabilities and Biosortia's harvesting and mining technologies, these assets represent a unique opportunity to accelerate the process of identifying and maturing a new class of immunotherapies.
FBNC ASBB

Hot Stocks

16:12 EDT First Bancorp receives regulatory approval for acquisition of ASB Bancorp - First Bancorp (FBNC) reports that it has now received all required regulatory approvals to acquire ASB Bancorp (ASBB). The ASB Bancorp shareholder meeting to approve the merger transaction is scheduled for September 19, 2017, and shareholders have been mailed the related proxy statement/prospectus. The Company expects to complete the merger of ASB Bancorp into First Bancorp and Asheville Savings Bank, SSB into First Bank on October 1, 2017. Prior to the merger date, ASB Bancorp shareholders will be mailed an election form with instructions and a deadline for electing their desired mix of cash and stock according to the terms of the merger. Asheville Savings Bank, SSB, will continue to operate as Asheville Savings Bank after the merger until the data processing system conversion, which the Company currently expects will occur in March 2018.
CCS

Hot Stocks

16:09 EDT Pico Holdings reports 8.8% passive stake in Century Communities
EIGI

Hot Stocks

16:08 EDT Endurance appoints Jeffrey Fox CEO - Endurance International Group Holdings announced that its board has appointed Jeffrey Fox to the role of president and CEO effective August 22. In addition to his role as president and CEO, Fox will also serve on Endurance's board. He succeeds Hari Ravichandran, the company's founder, who will resign effective August 22, as CEO and as a member of the board, in accordance with the CEO transition plan announced in April.
NSC

Hot Stocks

16:07 EDT Norfolk Southern names Cynthia Earhart as CFO, effective August 15 - Norfolk Southern announced that, following a comprehensive search process, its board of directors has appointed Cynthia Earhart as executive vice president and CFO, effective Aug. 15. Earhart succeeds Thomas Hurlbut, NS' vice president and controller, who has served as interim CFO since Aug. 1, following the retirement of Marta Stewart. Earhart, a certified public accountant, joined NS in 1985 and most recently served as executive vice president and chief information officer. In connection with her appointment as CFO, Earhart will retain her information technology responsibilities.
P

Hot Stocks

16:06 EDT Pandora names Roger Lynch CEO - Pandora announced that Roger Lynch will join the company as CEO and president, and a member of its board of directors, effective September 18, 2017. Naveen Chopra, who has served as Pandora's interim CEO since June 2017, will continue in his role as chief financial officer. In addition, Pandora announced it has also appointed Michael Lynton to its board of directors. Lynch has extensive experience leading, innovating and scaling consumer media and technology businesses globally, including having guided a number of companies through critical transformation periods. Through his media industry and subscription experience, Roger has frequently worked with large content providers to effect business models that embrace technological changes in distribution. As the founding CEO of Sling TV, Lynch led the creation, launch and growth of Sling TV to become the #1 Live OTT service in the U.S.
PLAB

Hot Stocks

16:05 EDT Photronics in pact to expand FPD manufacturing into China - Photronics announced plans to broaden its China expansion.Photronics UK, Ltd., a wholly owned subsidiary of Photronics hss signed an investment agreement with the Hefei State High-tech Industry Development Zone, a national-level high-tech zone in China, to establish a manufacturing facility in Hefei, China. Under the terms of the agreement, Photronics, through its subsidiary, will build and operate a facility to engage in research and development, manufacture and sale of FPD photomasks. In return, the High-tech Zone will provide certain investment incentives and support. "Today's announcement follows exactly one-year after our announcement to build an IC manufacturing facility in Xiamen, China, and is the next, logical step of our geographic expansion into the country," said Peter Kirlin, chief executive officer. "China is becoming an increasingly important manufacturing region for flat panel display, both LCD and AMOLED. The investment we are announcing today will place Photronics in the strategically enviable position as the largest merchant FPD photomask supplier in China, with leading edge technology for large format displays, including G10.5+, and AMOLED for mobile displays. We are pleased to partner with the High-tech Zone in Hefei and look forward to bringing our technology to the market, enabling our customers to make advanced displays." Investment Details Over the next five years, Photronics plans to invest a minimum of $160M under the agreement, in exchange for certain considerations and investment incentives from the High-tech Zone. Construction is planned to begin in late 2017 and production should start in the early spring of 2019. In conjunction with the investment agreement, Photronics has obtained customer commitments from two of the largest domestic display manufacturers in China, which should help quickly fill the planned production capacity of the facility and enable profitability soon after start up. Financing for the project will be a mix of transferred capital and cash, with the option of local financing. "The display market in China is very dynamic at the moment, with many leading-edge fabs under construction," said Kirlin. "We want to take a measured approach to our investment, while continuously monitoring the market as it develops. We have the discipline and flexibility to alter the speed of our investment, and even significantly increase the amount of capital committed if the market develops more quickly."
PLAB ALOT

Hot Stocks

16:03 EDT Photronics announces CFO Sean Smith will retire - Photronics (PLAB ) announced that Sean Smith will retire as senior vice president and CFO of the company, a position he has held since 2002, effective September 4. Smith will remain with the company as principle accounting officer through September, and then as a consultant through early December, to ensure a smooth transition. The company also announced that the board of directors has named John P. Jordan as senior vice president and chief financial officer, effective September 5, 2017. Jordan has most recently been interim vice president, CFO, treasurer and controller of AstroNova (ALOT).
AGNC

Hot Stocks

16:02 EDT AGNC Investment reports estimated net tangible book value $19.39 per share - The company announced its estimated net tangible book value of $19.39 per common share as of July 31.
PLAB

Hot Stocks

16:00 EDT Photronics trading halted, news dissemination
PPP

Hot Stocks

15:57 EDT Primero Mining trading resumes
TIPT

Hot Stocks

15:29 EDT Wexford Capital reports 8.02% passive stake in Tiptree Financial
AMZN

Hot Stocks

15:16 EDT Tiger Global lowers Amazon stake, keeps as top holding - Tiger Global lowered its stake in Amazon.com during the second quarter by 110,120 shares. The fund now owns 1.24M shares valued at around $1.2B. Amazon remains the fund's third largest holding.
NETS...

Hot Stocks

15:16 EDT Tiger Global takes stake in JC Penney, increases Microsoft stake - Tiger Global disclosed in an SEC filing its holdings as of June 30. Tiger's five new buys during the second quarter included, by size of position, Netshoes (NETS), Altice (ATUS), JC Penney (JCP), Okta (OKTA), and Cloudera (CLDR). Tiger exited three positions during the quarter, including by size of previous position, Netease (NTES), Mercadolibre (MELI), and Elf Beauty (ELF). Tiger increased its stake in six holdings, including by size of previous position, Microsoft (MSFT), TransDigm (TDG), Apollo Global (APO), FleetCor (FLT), and Comcast (CMCSA). Tiger reduced its stake in seventeen holdings, including by size of previous position, Charter (CHTR), Fiat Chrysler (FCAU), Domino's (DPZ), Alphabet (GOOG), and Alphabet (GOOGL). Tiger's top holdings as of June 30, in order of size, were Priceline (PCLN), JD.com (JD), Amazon (AMZN), TransDigm, and Apollo Global.
CMG YUM

Hot Stocks

15:16 EDT Chipotle names Laurie Schalow chief communications officer - Chipotle Mexican Grill (CMG) has hired Laurie Schalow as chief communications officer, a newly created position that will oversee all facets of Chipotle's internal and external communications functions. Schalow comes to Chipotle from YUM! Brands (YUM) where she held a variety of positions in communications, most recently serving as vice president of public affairs.
HLF...

Hot Stocks

14:46 EDT Herbalife, others fall with China cracking down on pyramid selling - Shares of Herbalife (HLF), Nu Skin Enterprises (NUS) and USANA Health Sciences (USNA) moved lower after China's State Administration for Industry & Commerce posted a statement on its website regarding pyramid selling. China is starting a three-month campaign to shut down organizations that use recruitment as a title to lure people into pyramid selling, the statement reads, according to Bloomberg. No companies were mentioned in the statement. Herbalife in afternoon trading is down 6%, or $4.18, to $61.65 while Nu Skin is down 9% to $55.12 and USANA is down 8% to $53.95. Reference Link
HLF...

Hot Stocks

14:15 EDT Herbalife, Nu Skin, USANA fall amid report said to discuss China probe - The move lower in shares of Herbalife (HLF), Nu Ski (NUS) and USANA (USNA) is being attributed to circulation of a report said to discuss probes of the multi-level marketing industry in China. Reference Link
GOOG...

Hot Stocks

13:55 EDT Former Tesla exec Chris Lattner says to join Google Brain next week - Chris Lattner tweeted: "I'm super excited to join Google Brain (GOOG) next week: AI can't democratize itself (yet?) so I'll help make it more accessible to everyone!" The Fly notes that Lattner left his role as VP of Autopilot software at Tesla (TSLA) after six months in June, commenting "Turns out that Tesla isn't a good fit for me after all. I'm interested to hear about interesting roles for a seasoned engineering leader!" Reference Link
CAPR

Hot Stocks

13:32 EDT Capricor rallies following study in European Heart Journal - A study published today by the European Heart Journal showed that cardiac stem cell infusions could someday help reverse the aging process in the human heart, EurekAlert reports. The cardiosphere-derived cells were manufactured by Capricor (CAPR), as the company's product, CAP-1002, have been used in other human clinical trials, the article points out. Shares of Capricor are up 17c to $1.22 in afternoon trading. Reference Link
FB

Hot Stocks

13:07 EDT Facebook Marketplace expanding to Europe - In a news release on Monday, Facebook said, "We're starting to roll out Marketplace to 17 countries across Europe including, Austria, Belgium, the Czech Republic, Denmark, Finland, France, Germany, Hungary, Ireland, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden and Switzerland, giving more people a single destination on Facebook to discover, buy and sell goods in their local communities." Reference Link
OMER

Hot Stocks

13:02 EDT Omeros sees continued improvement in OMS721 treated patients - Omeros announced additional follow-up data from patients with immunoglobulin, A IgA, patients by potentially precluding or substantially extending the time to the need for dialysis and reducing the risk of complications associated with progression of chronic kidney disease." Omeros has initiated a Phase 3 clinical program for OMS721 in IgA nephropathy and expects to begin a Phase 3 clinical trial in this disease later this year. FDA has granted OMS721 both breakthrough and orphan designations in IgA nephropathy. "The sustained duration of effect of OMS721 post-treatment underscores the drug's potential for episodic dosing in IgA nephropathy," said Gregory A. Demopulos, M.D., chairman and chief executive officer of Omeros. "We look forward to working with FDA to finalize the protocol for our Phase 3 clinical trial and open nephropathy treated with OMS721 in the Phase 2 clinical trial of glomerulonephropathy. OMS721 is Omeros' lead human monoclonal antibody targeting mannan-binding lectin-associated serine protease-2, MASP-2, the effector enzyme of the lectin pathway of the complement system. "The persistent reduction of proteinuria following completion of OMS721 treatment in these patients is impressive and provides additional evidence of the important role of the lectin pathway in IgA nephropathy," stated Geoffrey Block, M.D., director of clinical research at Denver Nephrology. "The improvements observed in eGFRs also suggest that OMS721 could provide further benefit to enrollment to IgA nephropathy patients later this year." In addition to its Phase 3 program in IgA nephropathy, OMS721 is also being evaluated in a Phase 3 clinical program for atypical hemolytic uremic syndrome and in a Phase 2 clinical program for hematopoietic stem cell transplant-associated thrombotic microangiopathy.
GE

Hot Stocks

12:58 EDT GE says Jeff Immelt to remain on Trump's manufacturing council - A statement from a GE spokesperson says: "GE has no tolerance for hate, bigotry or racism, and we strongly condemn the violent extremism in Charlottesville over the weekend. GE is a proudly inclusive company with employees who represent all religions, nationalities, sexual orientations and races. With more than 100,000 employees in the United States, it is important for GE to participate in the discussion on how to drive growth and productivity int he U.S., therefore Jeff Immelt will remain on the Presidential Committee on American Manufacturing while he is the chairman of GE." Reference Link
GE

Hot Stocks

12:56 EDT GE says Jeff Immelt to remain on Trump's manufacturing council

Hot Stocks

12:46 EDT Trump calls KKK, neo-Nazis and white supremacists 'criminals and thugs'
BDRBF

Hot Stocks

12:46 EDT Bombardier delivers first Learjet 75 jet to Brazilian customer - Bombardier Business Aircraft announced that it delivered its first Learjet 75 aircraft to a Brazilian customer. The aircraft joins Bombardier's business jet fleet of 685 Learjet, Challenger and Global aircraft in Latin America. Bombardier introduced a new level of passenger comfort in the Light jet category in 2016 with the introduction of a Learjet 75 aircraft featuring an innovative pocket door design. The pocket door divides the cabin from the entry area and reduces noise levels inside the cabin by up to eight decibels, while creating a distinct private living space for passengers.
KODK

Hot Stocks

12:40 EDT Kodak cutting 32 jobs in Finger Lakes region, WARN notice shows - Reference Link
TGT...

Hot Stocks

12:30 EDT Target names two senior food and beverage executives, Mark Kenny, Liz Nordlie - Target (TGT) announced the hire of two new senior food and beverage leaders. Mark Kenny and Liz Nordlie will join Target to accelerate the retailer's food and beverage strategy, aimed at offering a differentiated experience, with an emphasis on fresh produce, convenient eating and a curated assortment of affordable and accessible owned and national brands. Mark Kenny will join Target as vice president divisional, meat and fresh prepared food where he will oversee the meat, seafood, deli, bakery and prepared food categories. Kenny joins Target from Walmart (WMT), where he most recently was the senior director of private brands, deli and bakery. Liz Nordlie will join Target as vice president, product design and development for food and beverage. Most recently, Nordlie was the president of General Mills (GIS) baking division.
AAPL

Hot Stocks

12:18 EDT Apple CEO says white supremacy, racism a 'moral issue' - Apple CEO Tim Cook just tweeted, "We've seen the terror of white supremacy & racist violence before. It's a moral issue - an affront to America. We must all stand against it."
BK

Hot Stocks

12:00 EDT BNY Mellon to reschedule Investor Day to late winter or early spring 2018 - BNY Mellon announced the company is rescheduling its Investor Day, originally set for November 16, 2017, to late Winter or early Spring of 2018. The company will confirm a new date soon.
AMRN

Hot Stocks

11:34 EDT Amarin falls after announcing continuation of Vascepa trial - The shares of Amarin (AMRN) are falling after the company announced that the interim results of a study of its Vascepa drug were not sufficiently positive to trigger a halt of the study. Vascepa lowers the levels of triglycerides, a type of fat in the blood which is believed to lead to heart attacks. Clinical trials that have shown very successful results are sometimes halted to reduce expenses and enable more patients to receive the treatment being studied. Research firm Cantor Fitzgerald remained upbeat on Amarin following today's news. NEWS: An independent committee determined that the interim results of a study of Vascepa were not sufficiently positive to trigger a halt to the study, Amarin reported earlier today. The committee "has recommended that the trial continue as planned without modification," the company stated. The criteria for stopping the trial early "were intentionally set high" because stronger results" will be obtained if the trial is completed, Amarin stated. The final results of the trial are expected in the second or third quarter of 2018, it added. ANALYST REACTION: The current study of Vascepa could result in about 75M patients being eligible for the drug, up from about 4M now, wrote Cantor analyst Louise Chen. The study could also "create a multibillion dollar market opportunity" by establishing a direct cause/effect relationship "between triglyceride levels and cardiovascular risk," she stated. Chen kept a $10 price target and an Overweight rating on the stock. PRICE ACTION: In morning trading, Amarin fell 2.8% to $3.17.
WOOF ZTS

Hot Stocks

11:31 EDT VCA Animal Hospitals, Zoetis partner on study on Clavamox chewable tablets - VCA Animal Hospitals (WOOF) continues to support clinical research with their Clinical Studies program. In a recent collaboration, VCA partnered with Zoetis (ZTS) to conduct a clinical study that tested the palatability of Clavamox Chewable tablets with client-owned dogs at VCA veterinary hospitals across the U.S. The study was conducted across VCA's national network of hospitals in accordance with a protocol approved by FDA's Center for Veterinary Medicine for a chewable version of an incredibly important, and previously approved, veterinary antibiotic. A total of 1,567 doses were administered to 112 dogs, resulting in an 83% overall voluntary acceptance rate for Clavamox Chewable when offered from an empty bowl or owner's hand.
UA UAA

Hot Stocks

11:22 EDT Under Armour: 'No place for racism or discrimination in this world' - Under Armour tweeted, "We are saddened by #Charlottesville. There is no place for racism or discrimination in this world. We choose love & unity. - CEO Kevin Plank." Reference Link
AMZN

Hot Stocks

11:20 EDT Amazon's AWS announces Amazon Macie security service - Amazon Web Services announced Amazon Macie, a new security service that "uses machine learning to help customers prevent data loss by automatically discovering, classifying, and protecting sensitive data in AWS. Amazon Macie recognizes sensitive data such as personally identifiable information or intellectual property, and provides customers with dashboards and alerts that give visibility into how this data is being accessed or moved."
AMZN

Hot Stocks

11:19 EDT Amazon Web Services makes AWS Glue available to all customers - Amazon Web Services has launched AWS Glue, a fully managed extract, transform, and load service that "makes it easy for customers to prepare and load their data into Amazon Simple Storage Service, Amazon Redshift, Amazon Relational Database Service, and databases running on Amazon Elastic Compute Cloud for query and analysis. Customers can create and run an ETL job with a few clicks in the AWS Management Console."
ATUS

Hot Stocks

11:03 EDT Altice USA's FTTH network on track to reach 1M homes constructed in 2018 - Altice USA provides an update on its fiber-to-the-home network deployment. Design and construction have commenced for several hundred thousand homes concurrently in areas of New York, New Jersey and Connecticut. The company is on track to reach one million homes constructed by year end 2018.
CG

Hot Stocks

11:02 EDT Funds advised by Apax to acquire ECi Software Solutions - Funds advised by Apax Partners announced that they have reached a definitive agreement to acquire ECi Software Solutions, a provider of enterprise resource planning software solutions to small- and medium-sized businesses across the distribution, field services, building and construction and manufacturing industries. ECi is currently owned by affiliates of The Carlyle Group and Level Equity. Carlyle will retain a minority ownership position in the combined company. The transactions are expected to close in the third quarter of 2017, subject to customary closing conditions.
LFUS RRD

Hot Stocks

11:01 EDT Littelfuse says Jeffrey Gorski to succeed John Quille as CAO - Littelfuse (LFUS) announced the appointment of Jeffrey Gorski as VP and Chief Accounting Officer. In his role, Gorski will be responsible for worldwide corporate and technical accounting, SEC reporting and shared services, and will report directly to the company's EVP and CFO, Meenal Sethna. Gorski will succeed John Quille who is retiring and will remain in an advisory role during the transition. Most recently, Gorski served as SVP and Chief Accounting Officer of R.R. Donnelley (RRD).
LMT

Hot Stocks

11:00 EDT Lockheed Martin gets $161M US Army contract for ATACMS missiles - Lockheed Martin has received a $161M production contract for the Army Tactical Missile System, ATACMS, missile for the U.S. Army. The missiles will be produced at Lockheed Martin's Precision Fires Production Center of Excellence in Camden, Arkansas. The contract calls for the production of 150 ATACMS missiles as part of the ATACMS Service Life Extension Program. "The ATACMS Service Life Extension Program takes existing missiles and refurbishes them, resetting their shelf life," said Scott Greene, vice president of Precision Fires at Lockheed Martin Missiles and Fire Control. "ATACMS provides the combatant commanders with critical, deep-strike capability to service high-value targets in all weather conditions."As part of the U.S. Army's ATACMS Service Life Extension Program, the modernization process disassembles and demilitarizes ATACMS Block 1 and 1A warheads, replacing them with new unitary warheads. The process also resets the missile's 10+ year shelf life. ATACMS is the U.S. Army's only tactical long-range precision strike surface-to-surface weapon system. ATACMS missiles can be fired from the entire family of Multiple Launch Rocket System launchers.This is the first production contract for Modernized ATACMS missiles for the U.S. Army. Lockheed Martin has produced more than 3,800 ATACMS missiles. More than 600 ATACMS have been fired in combat, and the system has demonstrated extremely high rates of accuracy and reliability while in theater. Each ATACMS missile is packaged in a Guided Missile Launch Assembly pod, and is fired from the MLRS family of launchers.
SNAP

Hot Stocks

10:47 EDT Snap in the spotlight amid employee lockup expiration - While some lockup agreements related to Snap (SNAP) IPO expired on July 31, employees were subject to a pre-earnings blackout period and only today are able to sell an estimated 782M shares on the public markets for the first time. LOCKUP EXPIRATION: The lockup agreements related to Snap's IPO expired on Saturday, July 29, with the first day of trading on Monday, July 31. With the lockup expiring before Snap's second quarter earnings release, employees were not able to sell any shares until their trading window opened today. In a research note ahead of the expiration, JPMorgan analyst Doug Anmuth told investors that he expected downside into and after that initial date. The analyst also pointed out that the 782M shares that become available today include about 600M from directors, executive officers, and other affiliates and approximately 182M from other employees. On August 31, another 20M shares could be up for grabs as the 180-day lockup period expires, he noted. While Anmuth acknowledged that Snap's product innovation continues with Snap Map and other new creative capabilities, and self-serve Snap Ads and on-demand geofilters on the advertising side, he expects Snap to remain disciplined around the quality of ads on its platform. Additionally, Anmuth noted that Snap shares also may lack specific valuation support, and earnings, EBITDA, and free cash flow are likely to remain negative the next couple years. PRICE ACTION: In late morning trading, shares of Snap have gained almost 10% to $12.97, but still trading below the $17 IPO price.
IP...

Hot Stocks

10:39 EDT International Paper upgraded after containerboard price increases - DA Davidson upgraded packaging maker International Paper (IP) to Buy from Neutral, saying that the company is benefiting from successful containerboard price increases, strong box shipments and a rebound in its pulp business. PRICES, BOX SHIPMENTS: Two increases in containerboard prices were successfully implemented since International Paper reported its fourth quarter results, noted DA Davidson analyst Steven Chercover. Meanwhile, box shipments increased 3% in the first half of the year, he added. PULP BUSINESS, MIX: The earnings before interest, taxes, depreciation and amortization of International Paper's pulp business should jump 42% in fiscal 2018 after fluff prices rose, the analyst stated. Additionally, fluff looks poised to make up a higher percentage of the company's revenue going forward, boosting the company's overall results, according to Chercover. OVERALL OUTLOOK: International Paper's overall comp sales should resume increasing this quarter and its profits should rise by 19% in Q3, which would be the first increase in its profits in six quarters, according to Chercover. Moreover, the stock's multiple should increase as investors become more confident in the company's containerboard business and it generates strong free cash flow, Chercover predicted. He kept a $62 price target on the stock. PRICE ACTION: In morning trading, International Paper rose 2.2% to $53.75. Other packaging makers also climbed, with KapStone Paper (KS) advancing 1.4% to $22, Packaging Corp of America (PKG) rising 1% to $108.60, and WestRock (WRK) adding 1.5% to $56.45.
EQT...

Hot Stocks

10:36 EDT Jana bought EQT, Zimmer and Pandora during Q2 - Jana Partners disclosed in an SEC its holdings as of June 30. Jana made 15 new buys during the second quarter, including, by order of size, EQT Corporation (EQT), Zimmer Biomet (ZBH), Pandora (P), Molina Healthcare (MOH) and CDK Global (CDK). Jana also bought 600,000 shares of Blue Apron (APRN) in the quarter. The fund exited 13 positions during the quarter, including by size of previous position, Willis Towers Watson (WLTW), Aetna (AET), Alliance Data Systems (ADS), Shire (SHPG) and Bristol-Myers (BMY). Jana increased its stake in 8 holdings, including by size, Whole Foods (WFM), HP Enterprise (HPE), HD Supply (HDS), NuVasive (NUVA) and Zayo Group (ZAYO). The fund reduced its stake in 12 holdings, including by size, Universal Health (UHS), Dow Chemical (DOW), Conagra Brands (CAG), Sherwin-Williams (SHW) and Salesforce (CRM). Omega's top holdings as of June 30, in order of size, were Whole Foods, Tiffany (TIF), EQT, Liberty Broadband (LBRDA) and Zimmer.
MXL...

Hot Stocks

10:29 EDT Cooperman's Omega buys MaxLinear, Ocwen and L Brands in Q2 - Leon Cooperman's Omega Advisors disclosed in an SEC filing its holdings as of June 30. Omega made 21 new buys during the second quarter, including, by order of size, MaxLinear (MXL), Ocwen Financial (OCN), Covanta (CVA), L Brands (LB) and Trinity Industries (TRN). Omega exited 24 positions during the quarter, including by size of previous position, Walgreens Boots Alliance (WBA), TRI Pointe (TPH), Williams Partners (WPZ), Humana (HUM) and Pandora Media (P). The fund increased its stake in 19 holdings, including by size, Microsoft (MSFT), Sinclair Broadcast (SBGI), Valvoline (VVV), Nabors Industries (NBR) and Zynga (ZNGA). Omega reduced its stake in 16 holdings, including by size, HRG Group (HRG), Altisource Portfolio Solutions (ASPS), Arris (ARRS) and Lowe's (LOW). Omega's top holdings as of June 30, in order of size, were Alphabet Class A (GOOGL), First Data (FDC), United Continental (UAL), AerCap (AER) and Dow Chemical (DOW).
SYY

Hot Stocks

10:28 EDT Sysco sees achieving high end of $600M-$650M adjusted operating income target - Says will share new three-year plan for 2018-2020 period later this calendar year. The company says "making our way through inflationary environment." Says change from deflation to inflation has been "fairly rapid." Says move from deflation to inflation pressures gross margin as percentage of sales, but doesn't see a negative impact on Sysco's ability to grow gross profit dollars. Comments taken from the Q4 earnings conference call. Sysco is down 1.4% to $50.88 in morning trading.
NFLX DIS

Hot Stocks

10:27 EDT Analyst sees Disney loss having minimal impact on Netflix subscribers - Although Netflix (NFLX) shares slipped following Disney's (DIS) announcement that the company was ending its distribution agreement with the former, Piper Jaffray analyst Michael Olson told investors that he believes the loss will have a minimal impact on the streaming service subscribers. SURVEY SAYS: In a research note to investors this morning, Piper Jaffray's Olson says Disney ending its agreement for distribution of certain content is a negative headline, but it will have "minimal impact" on Netflix. This follows his firm survey of over 500 U.S. Netflix subscribers, asking what percent of their Netflix time is spent on Disney. The analyst pointed out that Piper found that "only" around 20% of subscribers spend greater than 10% of their Netflix time viewing Disney content. Further, he expects "almost none" of the remaining 80% of subscribers to cancel due to the loss of Disney. The 20% of heavier Disney viewers are unlikely to cancel unless Disney accounts for a larger portion, greater than 40%, of their Netflix viewing time, Olson contended. While Olson recognized the strength of Disney's content, particularly for younger children, the analyst noted that he believes Netflix can license similar genre content from other sources and/or use the cost savings for original programming. Netflix is likely already in the process of determining how to effectively reallocate funds previously earmarked for Disney, he said, adding that the company has nearly 18 months to plan for this change. The analyst reiterated an Overweight rating and $215 price target on Netflix's shares. ENDING AGREEMENT: Last week when Disney reported third quarter earnings, the company announced that it will launch its ESPN-branded multi-sport video streaming service in early 2018, followed by a new Disney-branded direct-to-consumer streaming service in 2019. Additionally, Disney said it will end its distribution agreement with Netflix for subscription streaming of new releases, beginning with the 2019 calendar year film slate. PRICE ACTION: In Monday morning trading, shares of Netflix have dipped 0.66% to $170.27, while Disney's stock is fractionally up to $102.20.
APRN

Hot Stocks

10:26 EDT JANA bought 600,000 shares of Blue Apron in Q2
MXL...

Hot Stocks

10:24 EDT Cooperman's Omega buys MaxLinear, Ocwen and L Brands in Q2 - Leon Cooperman's Omega Advisors disclosed in an SEC filing Friday after the close its holdings as of June 30. Omega made 21 new buys during the second quarter, including, by order of size, MaxLinear (MXL), Ocwen Financial (OCN), Covanta (CVA), L Brands (LB) and Trinity Industries (TRN). Omega exited 24 positions during the quarter, including by size of previous position, Walgreens Boots Alliance (WBA), TRI Pointe (TPH), Williams Partners (WPZ), Humana (HUM) and Pandora Media (P). The fund increased its stake in 19 holdings, including by size, Microsoft (MSFT), Sinclair Broadcast (SBGI), Valvoline (VVV), Nabors Industries (NBR) and Zynga (ZNGA). Omega reduced its stake in 16 holdings, including by size, HRG Group (HRG), Altisource Portfolio Solutions (ASPS), Arris (ARRS) and Lowe's (LOW). Omega's top holdings as of June 30, in order of size, were Alphabet Class A (GOOGL), First Data (FDC), United Continental (UAL), AerCap (AER) and Dow Chemical (DOW).
ZYNE

Hot Stocks

10:23 EDT Zynerba slumps after Phase 2 STOP trial fails to meet primary endpoint - Shares of Zynerba Pharmaceuticals (ZYNE) plunged in morning trading after the company's Phase 2 STOP trial of ZYN002 failed to meet its primary endpoint. The disappointing results follow news earlier this month that ZYN002 did not show significant seizure reduction in its Phase 2 STAR 1 trial. PHASE 2 STOP TRIAL: Zynerba this morning reported top line results from its Phase 2 STOP trial assessing ZYN002 for the treatment of knee pain due to osteoarthritis. The company said the study did not achieve its primary endpoint of a statistically significant reduction from baseline in the weekly mean of the 24-hour worst pain score at week 12 for either dose. However, Zynerba said the study did demonstrate significantly significant results on several of its secondary endpoints, including worst average daily pain scores and an improvement in the WOMAC physical function score. Armando Anido, Chairman and Chief Executive Officer of Zynerba, commented that despite not meeting the primary endpoint, results of the study "are very encouraging" as data from the STOP trial will help shape future studies with ZYN002 in osteoarthritis." Anido noted that Zynerba plans to request an end of Phase 2 meeting with the U.S. Food and Drug Administration, and sees the meeting taking place before the end of the year. It intends to move ZYN002 into Phase 3 development for OA. Zynerba is also currently evaluating ZYN002 in an exploratory Phase 2 FAB-C study in children with Fragile X syndrome, and top line data are expected by the end of September. FAILED PHASE 2 STAR 1 TRIAL: On August 7, Zynerba announced that ZYN002 did not demonstrate a statistically significant reduction of focal seizures during the treatment period compared to the baseline period for either the high or low dose cohorts compared to placebo in the company's Phase 2 STAR 1 clinical trial. "We are very disappointed that the STAR 1 trial did not meet its primary endpoint in this patient population," Anido said at the time. RECENT ANALYST DOWNGRADES: Following the results of the STAR 1 trial, several analysts downgraded the stock, including analysts at Piper Jaffray, Cantor Fitzgerald. In addition, Maxim analyst Gabrielle Zhou downgraded Zynerba to Hold from Buy and removed her price target saying she's uncertain about the clinical pathway forward for the company following the failed Phase 2 study. H.C. Wainwright analyst Corey Davis also downgraded the name to Neutral and cut his price target for the shares to $7 from $30. Davis said the direction is unclear for ZYN002 and removed all revenues for ZYN002 in epilepsy from his model. Additionally, Roth Capital analyst Michael Higgins downgraded Zynerba to Neutral from Buy and cut his price target for the shares to $7 from $30 and said he he is "surprised and disappointed" that ZYN002 missed the primary endpoint in its first Phase 2 study. Higgins likes ZYN002's outlook in the 16-patient Fragile X Syndrome Phase 2 study but says he cannot recommend Zynerba shares ahead of the Phase 2 osteoarthritis trial. In a prior research note to investors, Jefferies analyst Biren Amin pointed out that the STAR-1 trial represents a "critical catalyst" for Zynerba as it provides the first proof of concept for transdermally delivered CBD. PRICE ACTION: Zynerba dropped 20.6% to $5.58 in morning trading. Shares are down 64.5% year-to-date.
DUK

Hot Stocks

10:22 EDT Duke Energy Renewables to acquire 24.9MW solar project from Invenergy - Duke Energy Renewables is acquiring the 24.9-megawatt, MW, Shoreham Solar Commons project on Long Island from Invenergy.The project, currently under construction by Invenergy, is located in Brookhaven, New York, about 60 miles east of Manhattan. It is being built on the grounds of the former Tallgrass Golf Course and is expected to be complete in the second quarter of 2018. The Long Island Power Authority, LIPA, will purchase the power under a 20-year agreement. "We are excited to enter New York with a renewables project that offers many benefits to the state and local community," said Rob Caldwell, president, Duke Energy Renewables and Distributed Energy Technology. "The solar project will help meet the energy needs of LIPA's customers while delivering tremendous economic and environmental benefits."The project is expected to create more than 175 local jobs during construction and generate between $700,000 and $900,000 in annual tax revenue for the local community.Invenergy recently closed construction financing for the project with MUFG, the administrative agent and lead arranger. Duke Energy Renewables will close on the transaction post-construction, pending federal and local approvals.
RTN

Hot Stocks

10:10 EDT Raytheon elects Robert Work to board of directors - The Board of Directors of Raytheon has elected Robert O. Work as a director, effective immediately. Work was appointed the 31st Deputy Secretary of Defense by President Barack Obama in 2014, a position he held through July 2017.
ANY

Hot Stocks

10:09 EDT Sphere 3D advances after executing a private placement for $3M - Sphere 3D Corp announced earlier that it has has executed a private placement for gross proceeds of U.S. $3M.The placement consists of a total of 600,000 "Units," as further defined below, at a purchase price of U.S. $5.00 per Unit. Each Unit consists of one common share and one warrant to purchase one common share. The warrants are exercisable to purchase 600,000 common shares in the aggregate and have an exercise price of U.S. $5.25 per share, a 5-year term, and are exercisable in whole or in part at any time prior to expiration. MF Ventures, which beneficially owns, directly or indirectly, securities of the company carrying more than 10% of the voting rights attached to the outstanding voting securities of the company, participated in the private placements by acquiring 300,000 common shares and warrants to purchase 300,000 common shares. As a result, the participation of MF Ventures, constitutes a "related party transaction" within the meaning of Canadian Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions. Shares of Sphere 3D are up 6.4% to $4.61 in early trading.
VZ

Hot Stocks

10:08 EDT Verizon says received 138,773 requests for customer data in 1H17 - Reference Link
FIBK

Hot Stocks

10:02 EDT First Interstate announces merger of Bank of the Cascades into First Interstate - Less than three months after the completion of its acquisition of Cascade Bancorp, First Interstate BancSystem announced that it has consolidated its two subsidiary banks by merging Bank of the Cascades into First Interstate Bank. As a result of this merger, all former Bank of the Cascades locations are now operating under the First Interstate Bank name.
ITRN

Hot Stocks

10:01 EDT Ituran to expand into Indian market with JV agreement with Lumax - Ituran Location and Control, together with Lumax Auto Technologies Ltd part of Lumax DK Jain Group, India, announced the signing of joint venture agreement for sale of telematics products and services to the Indian automotive industry. The new JV company will be called Lumax Ituran Telematics Pvt Ltd. According to the agreement, Lumax Auto Technologies will own 50% of the joint venture, with Ituran owning the remaining 50%. The JV will tap into this large market, which currently has low penetration of advanced telematics technology. The JV will sell Ituran's telematics products and services, adapted to the Indian automotive industry.
SYY

Hot Stocks

09:54 EDT Sysco sees inflation continuing for balance of CY18 - Sees inflation continuing for balance of CY18. Sees FY18 CapEx approximately 1.3%-1.4% of sales. Sysco says it will continue to grow the dividend and make opportunistic share repurchases and buybacks to offset dilution. Comments from slides that will be presented on the Q4 earnings conference call.
PPP

Hot Stocks

09:53 EDT Primero Mining trading halted, news pending
GS

Hot Stocks

09:41 EDT Goldman Sachs CEO: 'Isolate those who try to separate us' - Goldman Sachs Chairman and CEO Lloyd Blankfein tweeted: "Lincoln: 'A house divided against itself cannot stand.' Isolate those who try to separate us. No equivalence w/ those who bring us together." Reference Link
JASN

Hot Stocks

09:38 EDT Jason Industries announces CFO transition - Jason Industries announced that Sarah Lauber, Senior Vice President & CFO, has given notice that she will be leaving the company on August 25, 2017 to pursue another opportunity. Chad Paris, currently Jason's Vice President - Investor Relations & Finance Finishing Americas, has been promoted to succeed Lauber as Jason's Vice President & CFO, and he will also serve as the company's principal financial and accounting officer.
MDT

Hot Stocks

09:32 EDT Medtronic announces global randomized Resolute Onyx DES trial - Medtronic announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy - the combination of aspirin and an anti-clotting medication - in patients implanted with the Resolute Onyx Drug-Eluting Stent during percutaneous coronary intervention. Designed to evaluate clinical DAPT outcomes between two DES for the first time ever, the RESOLUTE ONYX ONE-MONTH DAPT Study intends to help inform DAPT guidelines for newer-generation DES that currently favor bare-metal stents for patients with stable ischemic heart disease who might require a shorter dual antiplatelet regimen. The study further demonstrates the significant clinical investment from Medtronic to provide relevant DAPT evidence to physicians for both current and previous generation DES, including the Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates Study that showed significant safety benefits with a previous generation DES vs. BMS in patients who would typically not receive a DES, such as those at a high risk for bleeding.
MRK...

Hot Stocks

09:25 EDT Merck CEO takes stand against 'intolerance,' resigns from Trump council - Shares of Merck & Co (MRK) are in focus in morning trading after its chairman and chief executive announced his resignation from President Donald Trump's American Manufacturing Council. Soon after the statement, Trump tweeted that Frazier will have "more time" to lower drug prices. FRAZIER RESIGNS FROM MANUFACTURING COUNCIL: Merck & Co Chairman and Chief Executive Officer Kenneth Frazier this morning announced his resignation from the president's American Manufacturing Council. "As CEO of Merck and as a matter of personal conscience, I feel a responsibility to take a stand against intolerance and extremism," Fraizer wrote in a tweet. "America's leaders must honor our fundamental views by clearly rejecting expressions of hatred, bigotry and group supremacy, which run counter to the American ideal that all people are created equal," he added." Shortly after Frazier announced his resignation, Trump responded by tweeting that that now that the CEO had resigned from the council, he will have more time to "LOWER RIPOFF DRUG PRICES!" WHAT'S NOTABLE: Over the weekend, a gathering of hundreds of white nationalists in Charlottesville, Virginia took a deadly turn when a car deliberately plowed into a group of counter-protesters and killed at least one person. Trump denounced an "egregious display of hatred and bigotry" and said "many sides" were involved. Frazier is not the first executive to leave presidential advisory councils in protest of Trump's policies. In June, Tesla (TSLA) CEO Elon Musk and Disney (DIS) CEO Bob Iger left Trump's Strategic and Policy Forum after the president said he would withdraw from the Paris climate accord. Musk also left Trump's manufacturing council. In June, Bloomberg said that the Trump administration was planning an executive order regarding U.S. drug costs, which may express support for value-based agreements via which drug companies and health insurers make arrangements to pay for products depending on how well they work. PRICE ACTION: Merck is up 0.3% ahead of the market open. OTHERS TO WATCH: Publicly traded large-cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
AZUL...

Hot Stocks

09:20 EDT On The Fly: Pre-market Movers - UP AFTER EARNINGS: Azul (AZUL), up 2%... VMware (VMW), up 4.4% after reporting preliminary second quarter results. ALSO HIGHER: Merck (MRK), up marginally after Chief Executive Officer Kenneth Frazier announced that he is resigning from the President's American Manufacturing Council. LOWER: Sysco (SYY), down fractionally after reporting quarterly results.
TRNO

Hot Stocks

09:17 EDT Terreno Realty sells buildings in Maryland for $40.5M - Terreno Realty Corporation sold two industrial properties located in Maryland's Baltimore/Washington Corridor on August 10 for a sale price of approximately $40.5M. The properties consist of one industrial building containing approximately 99,000 square feet on approximately 12.6 acres at 8730 Bollman Place in Savage, Maryland which is 100% leased to one tenant and two industrial buildings containing approximately 349,000 square feet on approximately 17.9 acres at 6675 Amberton Drive and 6660 Santa Barbara Road in Elkridge, Maryland which are 100% leased to 11 tenants. Bollman Place was purchased by Terreno on June 24, 2011 for approximately $7.5M. The estimated unleveraged internal rate of return generated by the investment was approximately 12.4%. Route 100 was purchased by Terreno on June 12, 2013 for approximately $16.7M. The estimated unleveraged internal rate of return generated by the investment was approximately 15.7%.
TGT

Hot Stocks

09:15 EDT Target to acquire transportation technology company Grand Junction - Target announced it has agreed to acquire Grand Junction, a transportation technology company, to improve and expand Target's delivery capabilities. The acquisition will also accelerate Target's investments and ongoing efforts to transform its supply chain. San Francisco-based Grand Junction offers a software platform that's used by retailers, distributors and third-party logistics providers to manage local deliveries through a network of more than 700 carriers. Currently, Grand Junction is working with Target on its same-day delivery pilot at the Target store in New York's Tribeca neighborhood. Upon deal close, Grand Junction's employees will become Target team members.
QTM

Hot Stocks

09:10 EDT Quantum board unanimously elects Raghu Rau as Chairman - Quantum announced that its board of directors has unanimously elected current director Raghu Rau as chairman, succeeding Paul Auvil, who will remain on the board. In addition, the company announced that Gregg Powers has resigned from the board, effective immediately. Quantum's Corporate Governance and Nominating Committee is also being reconstituted and will now consist of Rau, Clifford Press and Alex Pinchev as its members.
REGN

Hot Stocks

09:09 EDT Regeneron to discontinue development of suptavumab - Regeneron Pharmaceuticals announced that a Phase 3 study evaluating suptavumab, an antibody to respiratory syncytial virus, did not meet its primary endpoint of preventing medically-attended RSV infections in infants. Suptavumab did show signs of efficacy in a subgroup of patients. Adverse events were generally balanced between suptavumab and placebo. Regeneron plans to discontinue further clinical development of this antibody. "We are disappointed in these results, as we had hoped suptavumab might offer a new option for the thousands of infants impacted by serious RSV infections every year," said George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer of Regeneron. "Regeneron has a robust pipeline across many serious diseases, and we look forward to important data readouts from other programs in the coming weeks and months."
WWE

Hot Stocks

09:05 EDT WWE SummerSlam to return to Barclays Center in 2018 - Barclays Center, NYC & Company and WWE announced that SummerSlam Week will return to Brooklyn for the fourth consecutive year in August 2018 with SummerSlam, Monday Night Raw, SmackDown Live and NXT once again taking place at Barclays Center over four consecutive nights. SummerSlam takes place this Sunday, August 20, live from Barclays Center. The event, which streams live around the world on WWE Network, features the biggest stars of WWE, including John Cena, Brock Lesnar, Roman Reigns, Seth Rollins, Alexa Bliss, Jinder Mahal, Shinsuke Nakamura, Naomi, Braun Strowman, The New Day and many more. In addition, SummerSlam Week in Brooklyn features a series of activities including interactive fan experiences and community outreach programs designed to leave a lasting impact throughout the region. Ticket and suite information for SummerSlam in 2018 will be announced in the near future.
PPHM

Hot Stocks

09:05 EDT Ronin Trading, SW Investment respond to announcements by Peregrine - Ronin Trading and SW Investment Management, collectively the second largest stockholder of Peregrine Pharmaceuticals, with aggregate beneficial ownership of approximately 8.8% of the company's outstanding shares of common stock, issued the following statement with respect to Peregrine. "We find it outrageous that Peregrine's Board of Directors and management chose to fire roughly 20% of the Company's employees while doing nothing to address their own unjustifiable and egregious compensation. If the Company needs to reduce costs, the first place it should look is the preposterously high salaries of its own Board and management. We remind stockholders what Institutional Shareholder Services said in its 2016 proxy report on Peregrine: 'WITHHOLD votes are warranted for compensation committee members Carlton M. Johnson Jr., David H. Pohl, and Eric S. Swartz due to continued problematic pay practices and the board's failure to adequately respond to shareholder concerns.' On July 31, 2017, Peregrine's Board announced an intention to increase the size of the Board from four to up to seven members by adding up to three new directors with - unlike themselves - actual pharmaceutical and contract development and manufacturing experience. This was a laughable attempt to appear stockholder-friendly since it would brazenly further entrench the incumbents while allowing them to retain a majority of Board seats. Notably, the Company did not actually expand the size of the Board, presumably because the Board's announcement was purely reactive to our public criticisms and it had not successfully identified additional candidates to serve on its slate. It is no surprise to us that the Board appears to be having difficulty finding highly qualified, ethical people to serve as nominees alongside themselves, given their own questionable backgrounds and records of value destruction. Furthermore, based on the feedback we have received from many stockholders in recent weeks, we believe support for the Board at the 2017 Annual Meeting will be nearly nonexistent, thus making it even more difficult for the Board to find additional qualified nominees. In the event Peregrine proceeds with the expansion of the Board, we will timely nominate additional highly qualified director candidates to ensure that control of the Board does not remain with the incumbents or their hand-picked additions. We believe a similar problem exists with the Board's ability to identify the right candidate to serve as the President of Avid Bioservices. We doubt whether any qualified candidate would be interested in the position given the current leadership structure of the Company and lack of any strategic plan put forth by the Board. To the extent that a President of Avid is hired prior to the 2017 Annual Meeting, if elected, our director candidates intend to immediately evaluate the appropriateness of the hire. It is insulting to employees and stockholders alike that management and the Board were responsible for these unfortunate layoffs, but apparently unwilling to sacrifice anything personally. Recent actions by management and the Board further validate our belief that their only concern appears to be their own personal enrichment, which we are confident will soon (and to everyone's relief) be coming to an end. The facts remain clear, and given what we believe is the extraordinarily low likelihood of the incumbent independent Board members being reelected at the 2017 Annual Meeting, we call on Peregrine's independent directors, Carlton M. Johnson Jr., David H. Pohl and Eric S. Swartz, to resign their Board seats immediately. Peregrine can no longer afford to allow Peregrine's current leadership to needlessly destroy more value in a futile attempt to cling to their positions. We are confident that our director nominees are the right people to end Peregrine's culture of leadership unaccountability, and will be able to finally set Peregrine on a path towards value creation."
AMZN FICO

Hot Stocks

09:02 EDT Amazon says AWS selected by FICO as cloud provider - Amazon Web Services, an Amazon.com company (AMZN), announced that FICO (FICO) has selected AWS as its cloud provider. FICO has migrated several core applications, including myFICO.com and its flagship analytics platform, the Decision Management Suite, to AWS, and will migrate additional applications over the next three years.
LGF.A LGF.B

Hot Stocks

09:02 EDT Lionsgate, Redbox announce new day-and-date agreement - Redbox and Lionsgate have signed a new agreement making Lionsgate content available at Redbox kiosks the same day as retail sell-through dates. By the end of 2017, Redbox will have more than 41,500 kiosks nationwide, due to a robust national expansion of 1,500 net new kiosks this year, with even more planned in 2018.
TTEK

Hot Stocks

09:02 EDT Tetra Tech awarded $113M contract for EPA's watershed protection program - Tetra Tech announced that it has been awarded a five-year, $113M contract to provide technical support services for the U.S. Environmental Protection Agency Office of Water. Under this multiple-award contract, Tetra Tech will support the EPA Office of Water's Assessment and Watershed Protection Division in its efforts to assess and monitor water quality conditions, develop comprehensive tools to promote watershed protection, study point and nonpoint source pollution, and develop strategies for ecosystem restoration. Tetra Tech will provide technical services to support the EPA's mission in meeting the broad requirements under the Clean Water Act which affect rivers, lakes, streams, wetlands, and coastal waters in the United States. These services include the development of water quality and economic models, preparation of technical guidance documents and analytical methods, and development of innovative management strategies to protect and reuse watershed. Tetra Tech will work with EPA regions, states, and other stakeholders on data analytics and the interpretation of water quality, land-use, and spatial data.
AMZN...

Hot Stocks

09:01 EDT Amazon says AWS selected by Hulu as cloud provider - Amazon Web Services, an Amazon.com company (AMZN), announced that Hulu has selected AWS as its cloud provider, and leveraged AWS to launch its new, over-the-top live TV service. Hulu turned to AWS for a scalable, agile, and cost effective infrastructure to support the addition of more than 50 live channels for the Hulu with Live TV launch in May 2017. Hulu is a joint venture owned by 21st Century Fox (FOXA), Comcast (CMCSA), Disney (DIS) and Time Warner (TWX).
CRDS

Hot Stocks

09:00 EDT Crossroads Systems trading resumes
CLMT

Hot Stocks

08:57 EDT Calumet Specialty Products to sell Superior refinery and related assets - Calumet Specialty Products announced that it has signed definitive agreements to sell the ownership of its Superior, Wisconsin refinery and various related assets to Husky Superior Refining Holding Corporation, a wholly owned unit of Husky Energy. Under the agreement, Husky has agreed to pay $435M in cash plus an additional payment for net working capital, inventories, and reimbursement of certain capital spending. Had the transaction closed on June 30, the additional payment would have been $61.5M. The transaction is subject to customary closing conditions and regulatory approvals.
MRK

Hot Stocks

08:56 EDT Trump: Merck CEO to 'have more time to lower ripoff drug prices' - President Donald Trump tweeted, "Now that Ken Frazier of Merck Pharma has resigned from President's Manufacturing Council,he will have more time to LOWER RIPOFF DRUG PRICES!" Reference Link
ADP...

Hot Stocks

08:48 EDT Ackman's Pershing started buying ADP in Q2, exited Air Products - Bill Ackman's Pershing Square Capital Management disclosed in an SEC filing its holdings as of June 30. Pershing made one new buy during the quarter, 1.75M shares of ADP (ADP). The fund exited one stake, Air Products (APD). It increased its holding in one name, buying 1.14M shares of Howard Hughes (HHC), and lowered its stake in one name, Mondelez (MDLZ). Pershing's top holdings as of June 30, in order of size, were Restaurant Brands (QSR), Chipotle Mexican Grill (CMG), Mondelez, Howard Hughes and Platform Specialty Products (PAH).
STAY

Hot Stocks

08:47 EDT Extended Stay America announces credit rating upgrades - Extended Stay America announced upgrades on ESH Hospitality, Inc.'s unsecured bond and secured credit facility ratings. Moody's ratings on ESH Hospitality, Inc.'s Senior Unsecured Notes due 2025 were upgraded to B1 from B2, the Senior Secured Term Loan was upgraded to Ba3 from B1 and the Senior Secured Revolver was also upgraded to Ba3 from B1. The Outlook remains positive. The company's CFO, Jonathan Halkyard, commented, "We are pleased with the Moody's upgrades to our debt ratings. We believe these upgrades reflect the improvements made on our balance sheet over the last two years including a reduction in our outstanding debt, our strong operating performance and our commitment to continue to de-lever over the next 18 months."
SCHW

Hot Stocks

08:46 EDT Charles Schwab reports July net new assets $15.8B - The Charles Schwab Corporation released its Monthly Activity Report. Company highlights for the month of July 2017 include: Net new assets brought to the company by new and existing clients in July 2017 totaled $15.8B. Total client assets were a record $3.1T as of month-end July, up 15% from July 2016 and up 2% compared to June 2017. New brokerage accounts totaled 107,000 in July, up 27% from July 2016, representing a record-tying eighth consecutive month of new accounts in excess of 100,000.
CERC JNJ

Hot Stocks

08:42 EDT Cerecor announces divestiture of CERC-501 to Janssen Pharmaceuticals - Cerecor (CERC) announced that it has sold to Janssen Pharmaceuticals (JNJ) all of its rights to CERC-501 for initial gross proceeds of $25M, of which $3.75M was deposited into a 12-month escrow to secure future indemnification obligations to Janssen, as well as a potential future $20 million regulatory milestone payment. Under the terms of the agreement, Janssen will assume the ongoing clinical trials and be responsible for any new development and commercialization of CERC-501.
MRK

Hot Stocks

08:42 EDT Merck CEO Frazier resigns from President's American Manufacturing Council - Merck Chairman and CEO Kenneth Frazier announced on Twitter that he is resigning from the President's American Manufacturing Council. He said "Our country's strength stems from its diversity and the contributions made by men and women of different faiths, races, sexual orientations and political beliefs. America's leaders must honor our fundamental values by clearly rejecting expressions of hatred, bigotry and group supremacy, which run counter to the American ideal that all people are created equal. As CEO of Merck and as a matter of personal conscience, I feel a responsibility to take a stand against intolerance and extremism." Reference Link
TYME

Hot Stocks

08:41 EDT Tyme Technologies announces issuance of 2 new platform patents - Tyme announced the United States Patent and Trademark Office has issued patents, #9,585,841 and #9,724,657, that, individually and in combination, substantially expand the scope of intellectual property for Tyme's pipeline. Patent '841 describes the process for combining tyrosine derivatives with other compounds, including melanin, as a drug delivery pathway into cancer cells. Tyrosine is the core component of Tyme's SM-88 therapy and melanin is believed to enhance the oxidative effect of SM-88, which could be further amplified by intracellular delivery. Tyme believes both SM-88's human clinical trials as well as tyrosine-based products for diagnostic imaging have demonstrated that tyrosine is highly selective to cancer cells. Future development projects could combine other drugs with tyrosine to achieve targeted delivery of additional therapeutics into the tumor. Patent '657 describes a novel manufacturing technique to combine compounds under exceptional force. Tyme has demonstrated the use of this technique to combine tyrosine and melanin while maintaining the functionality of their original, separate components. '657 is not limited to Tyme's current product portfolio and could be utilized with a multitude of drug combinations.
MRK

Hot Stocks

08:40 EDT Merck CEO Frazier resigns from President's American Manufacturing Council
HEB

Hot Stocks

08:36 EDT Hemispherx commences human safety study of Ampligen plus FluMist - Hemispherx Biopharma announced that it has commenced full data analysis of an intranasal human safety study of Ampligen plus FluMist known as AMP-600. The study was previously closed, but the initiation of full data analysis awaited the FDA's evaluation of preliminary reports of blinded study findings. That evaluation was completed per formal notification from the FDA on August 9, 2017. Intranasal Ampligen was generally well-tolerated in the study.
IMMR

Hot Stocks

08:34 EDT Immersion, Yomuneco sign licensing agreement for gaming, VR applications - Immersion Corporation announced it has signed an end-user license agreement with Tokyo-based Yomuneco, which is an equity-method company of gumi. The agreement enables Yomuneco to add tactile feedback to its gaming applications using Immersion's TouchSense Force solution for the Unreal Engine design tool. Yomuneco is now developing a new VR role-playing game which is scheduled to be released in 2018. With Immersion's TouchSense Force solution, Yomuneco can develop haptic effects for its games and gaming platforms to create rich, multi-dimensional user experiences.
EVOK

Hot Stocks

08:34 EDT Evoke Pharma initiates comparative exposure PK study for Gimoti - Evoke Pharma announced the initiation of its comparative exposure pharmacokinetic, or PK, trial for Gimoti, the company's patented nasal delivery formulation of metoclopramide for the relief of symptoms associated with acute and recurrent diabetic gastroparesis. The study is designed to demonstrate that the proposed dose of Gimoti has similar systemic exposure to that of the listed drug, Reglan Tablets, and PK data will be part of the basis for the company's planned 505(b)(2) new drug application, or NDA, to the FDA. The study is a single dose, crossover design in which approximately 100 healthy volunteers will receive Reglan Tablets and three different doses of Gimoti. The study will be conducted by Spaulding Clinical Research, a clinical research organization, or CRO, that successfully completed the company's thorough ECG trial for Gimoti in 2014. The company expects to complete the analysis of the trial data and announce results in the fourth quarter of 2017, followed by a potential NDA submission in late 2017 or early 2018.
GMRE FBRC

Hot Stocks

08:32 EDT Global Medical REIT names Robert Kiernan CFO - Global Medical REIT (GMRE) announced that Robert Kiernan will join the company as its CFO and treasurer, effective August 23. Kiernan will oversee corporate finance, accounting, and capital and financing strategies for the company and will report to CEO David Young. Kiernan will succeed Donald McClure, who is pursuing other opportunities. Prior to joining the company, Kiernan served as the SVP, controller and chief accounting officer of FBR (FBRC) commencing in October 2007.
WU

Hot Stocks

08:32 EDT Western Union, Pay-O-Matic renew agreement with 7-year extension - Western Union announced it will continue its longstanding relationship with Pay-O-Matic, a check casher and financial services provider in the New York metropolitan area. The renewed relationship includes Western Union Money Transfer and money order services, as well as bill payment services. Under the terms of the agreement, customers at Pay-O-Matic's 150 store locations in Brooklyn, the Bronx, Queens, Manhattan and Long Island will be able to send money to 500,000 Western Union Agent locations in 200 countries and territories, and also pay their bills through the Western Union Quick Collect service.
GNE

Hot Stocks

08:32 EDT Genie Energy acquires Mirabito Natural Gas for $3M plus working capital - Genie Energy announced that its Genie Retail Energy division has acquired Mirabito Natural Gas, a Ft. Lauderdale, Florida-based natural gas supplier, from Angus Energy for $3M plus Mirabito's working capital. Mirabito Gas serves commercial and governmental customers throughout Florida. Its customer base comprises approximately 10,000 residential customer equivalents.
MMM MSFT

Hot Stocks

08:31 EDT 3M names Microsoft CFO Amy Hood to board - 3M (MMM) announced that Amy E. Hood, executive vice president and CFO, Microsoft (MSFT), has been elected to 3M's Board of Directors, effective August 13. Hood will serve on the 3M Board's finance committee.
DGLT

Hot Stocks

08:30 EDT Digiliti Money trading resumes
CERC

Hot Stocks

08:29 EDT Cerecor announces retirement of CEO Dr. Uli Hacksell - Cerecor announced that Dr. Uli Hacksell has retired as Cerecor's president and CEO, effective Monday, August 14, 2017. John Kaiser, Chief Business Officer of Cerecor, has been appointed Interim CEO. Cerecor's board has initiated a search for a permanent CEO. Dr. Hacksell will stay on as chairman of Cerecor's board.
CRDS

Hot Stocks

08:27 EDT Crossroads Systems trading halted, news pending
SSC

Hot Stocks

08:27 EDT Seven Stars Cloud Group announces two new separate JV partnerships - Seven Stars Cloud Group announced two additional joint venture partnership deals with entities that will integrate and gradually move certain segments of their operations towards SSC's VPaaS in early 2018. The first JV Partnership is with Ocasia Group Holdings, which is engaged in a broad range of activities including the trading of physical crude oil, fuel oil and refined oil products as well as oil storage facilities. Ocasia is a purchasing agent for major energy companies, including Petro China and China Petroleum & Chemical Corporation. The second is with Beijing Urban Construction Holding Materials Industry Co., a large international construction group engaged in general contracting, real estate development and design & real estate consultancy. Beijing Urban Construction has constructed many national and provincial key projects in China including the National Stadium, the National Theater for the Performing Arts, the National Museum, the National Indoor Stadium, the Olympic Basketball Stadium, the Olympic Village and Terminal 3 of Beijing Capital International Airport. Both businesses do billions of U.S. dollars a year in purchasing and procurement turnover and both are examples of the businesses that SSC will be looking to partner with moving forward.
FBIO

Hot Stocks

08:22 EDT Fortress Biotech forms new subsidiary - Fortress Biotech announced the formation of a new subsidiary company, Aevitas Therapeutics, to develop novel gene therapy approaches for complement-mediated diseases. The proprietary technology, licensed from a leading university, uses adeno-associated virus, or AAV,-based gene therapy to restore lasting production of functional complement regulatory proteins, providing a potentially curative treatment.
MANT

Hot Stocks

08:20 EDT ManTech wins $180M JPL contract - ManTech was awarded a $180M contract, with full potential value of $450M including contract extensions over a 10-year term, to manage and transform NASA's Jet Propulsion Laboratory, or JPL, Institutional Computing Environment, or ICE. The agreement is a subcontract for ICE under JPL's NASA prime contract. Under the agreement, ManTech will be responsible for the full range of ICE services used by JPL personnel in their support of the NASA mission: comprehensive IT support; collaborative engineering for the entire JPL community; integrated personal collaboration services; cybersecurity for all end users including off-site employees and contractors; cellular infrastructure; secure routing of communications to end user devices in accord with approval cycles; and all subscriber services, in a secure environment.
ABT ALR

Hot Stocks

08:14 EDT Abbott extends offer for Alere Series B Convertible Perpetual Preferred Stock - Abbott (ABT) announced that it is extending its previously announced tender offer to purchase for cash all outstanding shares of Series B Convertible Perpetual Preferred Stock of Alere (ALR) at a price of $402.00 per share of Preferred Stock, plus accrued but unpaid dividends to, but not including, the settlement date of the tender offer, net to the seller thereof in cash, without interest thereon and subject to any withholding of taxes required by applicable law. The Offer is being made pursuant to an Offer to Purchase, dated July 17, and in connection with Abbott's previously announced agreement to acquire Alere. The Merger is not conditioned upon, or otherwise subject to, the completion of the Offer. The Offer is being extended to allow additional time for the consummation of the Merger, which is a condition to the completion of the Offer. The Offer was previously scheduled to expire at 11:59 p.m., New York City time, on Friday, Aug. 11, 2017 and will now expire at 11:59 p.m., New York City time, on Thursday, Aug. 31, 2017. If, at the Expiration Date, any of the conditions to the Offer have not been satisfied or waived, Abbott may elect to further extend the Offer for any length of time and in its sole discretion, but is under no obligation to do so.
LPCN

Hot Stocks

08:13 EDT Lipocine announces FDA acknowledgement of TLANDO NDA resubmission - Lipocine announced that the FDA has acknowledged receipt of the company's New Drug Application, or NDA, resubmission for TLANDO, its oral testosterone product candidate for testosterone replacement therapy, or TRT, in adult males for conditions associated with a deficiency of endogenous testosterone, also known as hypogonadism. The FDA has deemed the resubmission a complete response to its June 2016 Complete Response Letter , or CRL, that requested additional information related to the dosing algorithm for the proposed label. The FDA has assigned a new Prescription Drug User Fee Act goal date of February 8, 2018. The TLANDO NDA is based on the results of the Dosing Validation, or DV, study. The DV study confirmed the efficacy of TLANDO with a fixed dose regimen without need for dose adjustment. TLANDO was well tolerated upon 52week exposure with no reports of drug related Serious Adverse Events.
BIOC

Hot Stocks

08:10 EDT Biocept enters exclusive distribution agreement with VWR - Biocept announces that it has signed an exclusive global Distribution Agreement excluding China, for the company's proprietary blood collection tubes with VWR International, the leading global independent provider of product and service solutions to laboratory and production customers. Biocept's BCTs allow for the intact transport of liquid biopsy samples for research use only from regions around the world. Commercial launch is anticipated to begin in the second half of 2017.
CBI

Hot Stocks

08:08 EDT CB&I wins storage project in Saudi Arabia - CB&I announced it has been awarded a contract by Tecnicas Reunidas, S.A. for new product storage tanks that will be part of a clean fuels expansion project at Saudi Aramco's refinery in Ras Tanura, Saudi Arabia. CB&I's scope includes the engineering, procurement, fabrication and construction of nine flat bottom tanks, as well as modifications to numerous existing tanks, all of which were previously supplied by CB&I. In support of Saudi Aramco's In-Kingdom Total Value Add program, CB&I will provide all fabrication and project management utilizing its local facilities in Al-Khobar. The project will facilitate CB&I's ongoing efforts to train, develop and employ Saudi Arab nationals in key positions.
INSE

Hot Stocks

08:07 EDT Inspired Entertainment adopts stockholder rights plan with a 20% threshold - Inspired Entertainment announced that on August 13 its Board of Directors unanimously adopted a stockholder rights plan with a 20% triggering threshold and declared a dividend distribution of one preferred share purchase right on each outstanding share of Inspired common stock. The rights plan is effective immediately and, if approved by stockholders at the Company's 2018 annual meeting, will expire on August 12, 2020. If stockholders do not approve the rights plan, it will expire on August 12, 2018. The rights plan was not adopted in response to any specific effort to acquire control of Inspired. The Board unanimously adopted the rights plan in response to the potential for a purchase or purchases of a substantial number of shares of Inspired common stock by any person or group that could gain a substantial, and potentially controlling, position in the Company through open-market purchases and/or private transactions without appropriately compensating all of the Company's stockholders for such control. In June 2017, contractual lock-up restrictions covering approximately 14.5 million of the approximately 22.4 million outstanding shares of Inspired common stock expired, and in July 2017, the Company registered approximately 16.7 million shares of Inspired common stock for resale by selling stockholders, including approximately 15.6 million shares of Inspired common stock beneficially owned by three stockholders. Although contractual lock-up restrictions covering approximately 2.2 million of such registered shares are in place through December 23, 2017, these restrictions expire if the last sale price of Inspired common stock equals or exceeds $12.00 per share for any 20 trading days within any 30-trading day period commencing after May 22, 2017. The Board implemented the rights plan as a means to ensure that all of Inspired's stockholders are treated fairly. The rights plan is designed to limit the ability of any person or group to gain.
NCIT

Hot Stocks

08:06 EDT HIG Capital affiliates complete tender offer to acquire NCI, Inc. - H.I.G. Capital announced the successful completion of the previously announced $20.00 per share cash tender offer for all of the outstanding shares of common stock of NCI, Inc. The tender offer, which was made pursuant to the Agreement and Plan of Merger entered into by NCI and private funds managed by an affiliate of H.I.G. on July 2, 2017, expired at 12:00 midnight, New York City time, on August 12, 2017. A total of 7,424,366 shares of Class A common stock of NCI and 4,500,000 shares of Class B common stock, collectively representing approximately 82.0% of the voting power of the shares of Class A and Class B common stock outstanding on a fully-diluted basis were tendered into and not withdrawn from the tender offer. According to the terms of the tender offer, all such NCI shares have been irrevocably accepted for payment, which will be made promptly. As a result of the tender offer and the merger, NCI will become a privately-held, indirect wholly-owned subsidiary of an affiliate of H.I.G. and NCI's common stock will cease trading on the NASDAQ Global Select Market. The merger is expected to be completed on Tuesday, August 15, 2017.
LMT

Hot Stocks

08:06 EDT Lockheed Martin named as prime contractor of USSOCOM program - Lockheed Martin has been named prime contractor of U.S. Special Operations Command's next-generation logistics and sustainment support program. The Special Operations Forces Global Logistics Support Services program is the competitive follow-on contract to the Special Operations Forces Contractor Logistics Support Services contract awarded in 2010 and managed by Lockheed Martin. SOF GLSS is USSOCOM's largest service contract vehicle, providing the full scope of logistics services required to support the U.S. Special Operations community. It is a 10-year Indefinite Delivery/Indefinite Quantity contract with an $8B ceiling. Under the SOF GLSS contract, U.S. Special Operations Forces will receive a wide variety of advanced logistics, maintenance and sustainment services across aviation, ground and maritime platforms. In addition, the Lockheed Martin SOF GLSS team will provide USSOCOM with total global logistics support services.
IMNP

Hot Stocks

08:05 EDT Immune Pharmaceuticals appoints Tony Fiorino as CMO, COO - Immune Pharmaceuticals announced that it has appointed Tony Fiorino, MD, PhD to the joint position of CMO and COO. Fiorino will be responsible for all research and development and clinical and manufacturing activities for the company's core pipeline assets, bertilimumab and nano-cyclosporin. He joins the company from Triumvira Immunologics, an immuno-oncology company developing a novel engineered T cell platform, where he served as president and CEO.
BGS ANFI

Hot Stocks

08:05 EDT B&G Foods names Bruce Wacha as EVP of Corporate Strategy & Business Development - B&G Foods (BGS) has appointed Bruce C. Wacha as EVP of Corporate Strategy and Business Development, a newly created position, effective August 21. In this role, Wacha will oversee the company's corporate strategy and business development, including mergers & acquisitions, capital markets transactions and investor relations and serve on the company's executive management team, reporting to President and CEO Robert C. Cantwell. Wacha joins B&G Foods from Amira Nature Foods (ANFI), where he spent three years as that company's CFO and executive director of the board of directors.
PG

Hot Stocks

08:01 EDT Procter & Gamble: Peltz seeking board seat 'to satisfy his own agenda' - The Procter & Gamble Company mailed a letter to its shareholders in connection with the company's upcoming 2017 Annual Meeting of Shareholders, to be held on October 10. The letter strongly recommends that shareholders vote the BLUE Proxy Card to maintain P&G's momentum and continue advancing its plan for the following reasons: "P&G is delivering growth and shareholder value with a strategy and plan that is working. P&G has transformed itself with a streamlined and focused portfolio of brands and categories. P&G is implementing significant productivity improvements to fuel sales and earnings growth and investment in our brands and categories. P&G has simplified its organization design to drive clear ownership and accountability for decisions and results by category. P&G is raising the bar to a new standard of excellence to meet the needs of consumers through noticeably superior innovation that is growing markets and improving value for consumers. The letter states P&G's belief that Mr. Peltz initiated the proxy contest to satisfy his own agenda and to meet the expectations of his limited partners. What's best for P&G right now is balance and focus, with the Board and employees continuing a steady commitment to a plan that is working. P&G will not benefit from change for the sake of change."
DGLT

Hot Stocks

07:55 EDT Digiliti Money trading halted, news pending
TPIC

Hot Stocks

07:48 EDT TPI Composites, Senvion sign wind blade supply agreement - TPI Composites announced that it is providing additional details regarding the signing of a new supply agreement that it previously disclosed on August 8. TPI has signed a multiyear supply agreement with Senvion S.A. to provide blades from two manufacturing lines for wind markets including Asia, Australia and South America. The blades will be produced at TPI's facility in Taicang Port, Jiangsu province, China with production planned to commence in Q1 2018. The blades will be manufactured using proprietary RodPack technology, a highly advanced material system that when used in the main girder, enables optimized blade design as well as faster and higher-quality blade production. Senvion purchased the RodPack technology in 2015 and has designed it into several blade models. As part of this agreement, TPI will establish high-volume, high-quality, low-cost supply of RodPack from its operations in China.
DSPG

Hot Stocks

07:45 EDT DSP Group announces new $10M stock repurchase program - DSP Group announced that in light of its strong cash position and its focus on shareholder value, the company's board has unanimously authorized the company to repurchase additional shares of the company's common stock in an aggregate amount of up to $10M.
RETA

Hot Stocks

07:42 EDT Reata says FDA confirms mFARS is acceptable enpoint for MOXIe trial - Reata Pharmaceuticals announced that the FDA confirmed that the modified Friedreich's Ataxia Rating Scale, or mFARS, is an acceptable primary endpoint for Part 2 of the MOXIe trial for omaveloxolone in Friedreich's ataxia, or FA. The FDA communication was made in response to the Company's request that the FDA confirm its prior guidance that, depending on the MOXIe trial results, mFARS could be appropriate to support approval of omaveloxolone for FA under Subpart H. In the recent communication, FDA indicated that it may consider either accelerated or full approval based on the overall results of the trial and strength of the data. FDA also recommended that the company extend the treatment duration for Part 2 of the study and add a straightforward patient-reported or performance-based outcome endpoint to the study.
NEFF

Hot Stocks

07:41 EDT Neff trading resumes
LLEX

Hot Stocks

07:33 EDT Lilis Energy provides Q2 operations update - Lilis Energy announced a second quarter operations and corporate update. "The initial production rates on our Delaware Basin wells continue to yield results above our expectations and are among the best in the basin. Our first three wells exceeded internal projections and we are confident that our fourth well, the Lion, is on track to repeat similar results," said Jim Linville, Lilis's CEO. "We are currently producing 2,674 net BOEPD and have increased our proved reserves to 10.4 MMBOE over the past six months. In conjunction with this, we continue to expand our acreage footprint and have accumulated approximately 10,500 net acres. Additionally, we completed a new midstream contract." "The Company remains well capitalized and in a strong position to take advantage of accretive acquisition opportunities within our core area of focus in Winkler, Loving and Lea counties. Additionally, our midstream contract with Lucid Energy is expected to improve our realized production, minimize curtailment and assist in increasing operating cash flows on a go-forward basis. Over the last few months, we have undertaken significant strides to strengthen our balance sheet which will allow us to exploit and de-risk our strong acreage position, to maximize shareholder value," said Joe Daches, Lilis's CFO.
NEFF HEES

Hot Stocks

07:32 EDT Neff board hasn't changed recommendation in support of H&E merger
NEFF HEES

Hot Stocks

07:31 EDT Neff announces receipt of superior proposal for $25 per share in cash - Neff Corporation (NEFF) announced that its Board of Directors has determined that an acquisition proposal received from a strategic bidder to acquire all of the outstanding shares of Neff common stock for $25.00 per share in cash constitutes a "Superior Proposal" as such term is defined in the company's previously announced agreement and plan of merger with H&E Equipment Services (HEES). The definitive terms and conditions of a merger agreement and other related agreements detailing the acquisition proposal have been fully negotiated, and such agreements are subject only to execution by the Company. In making its determination that the bidder's proposal constitutes a Superior Proposal, the Board consulted with its independent financial advisor and outside legal counsel. Under the terms of the Existing Merger Agreement, H&E agreed to acquire all of the outstanding shares of Neff common stock for $21.07 per share in cash, subject to certain potential downward adjustments. The company has provided notice to H&E of the Board's determination that the proposal constitutes a Superior Proposal. Under the Existing Merger Agreement, H&E has certain matching rights, including the right to propose modifications to the terms of the Existing Merger Agreement and related agreements prior to the expiration of a five business day period. The company is required to, and intends to, negotiate in good faith with H&E during this period. Under the Existing Merger Agreement, the company is required to pay a $13.2M termination fee to H&E if the Company terminates the Existing Merger Agreement in order to enter into an agreement with the bidder. The bidder has agreed to pay the termination fee to H&E on the company's behalf in such event. The company's Board has not changed its recommendation in support of the H&E merger. There can be no assurance that a transaction with the bidder will result from the bidder's offer or that any other transaction will be consummated.
LLEX

Hot Stocks

07:31 EDT Lilis Energy, Lucid Energy Group enter agreement in Permian Basin - Lilis Energy announced it has entered into a long-term gas gathering, processing and purchase agreement with an affiliate of Lucid Energy Group to support Lilis's active drilling program in the Permian's Delaware Basin. Lucid will receive, gather and process Lilis's gas production from certain production areas located in Lea County, New Mexico and in Loving and Winkler counties, Texas. The agreement secures sufficient term and capacity for Lilis during its development and exploitation life cycle of the production areas committed to the new agreement.
AST

Hot Stocks

07:30 EDT Asterias announces AST-VAC2 development milestone - Asterias Biotherapeutics, announced that Cancer Research UK, supported by Asterias technical personnel, has successfully completed manufacture of the first cGMP, or current Good Manufacturing Practice, clinical grade lot of AST-VAC2, which meets all specifications for release. This lot will provide clinical trial material for patients enrolling in the first clinical study evaluating AST-VAC2 in non-small cell lung cancer.
CAMT

Hot Stocks

07:29 EDT Camtek, Sun Chemical establish strategic cooperation - Camtek has established a strategic cooperation with Sun Chemical, a leading producer of printing inks, coatings and supplies, pigments, polymers, liquid compounds, solid compounds, and application materials. In the framework of this cooperation, Sun will develop liquid solder mask ink to be used in Camtek's inkjet system for PCB applications. The resulting ink may also target all other end user markets for PCB manufacturing, including the high-end automotive sector, with soldermask technology capable of meeting the most stringent OEM specifications, and the parties will share profits derived from the ink developed.
NEFF

Hot Stocks

07:26 EDT Neff trading halted, news pending
CTSO

Hot Stocks

07:16 EDT CytoSorbents awarded $719,000 grant from U.S. Army - CytoSorbents announced that it has been awarded a grant from the U.S. Army Medical Research and Materiel Command to develop new blood purification therapies to acutely stabilize victims of severe burn injury. This work aligns with the Combat Casualty Care Research Program burn injury task area of the Forward Surgical En Route and Critical Care research portfolio. This grant provides for a maximum funding of $719,000 over four years. The company will collaborate with leading burn researchers at the U.S. Army Institute of Surgical Research in San Antonio, Texas.
R

Hot Stocks

07:10 EDT Ryder to become exclusive sales channel partner, service provider for Chanje - Ryder System announced that the company will become the exclusive sales channel partner and service provider for Chanje, a new California based medium-duty electric vehicle and energy services company. As part of their future technology strategy, Ryder has placed its initial order of Chanje vehicles, the first of which will be distributed to Ryder locations in strategic U.S. markets and be available for ChoiceLease customers in the coming weeks. Additionally, a portion of the new vehicles will be added to Ryder's commercial rental fleet so that customers will have the opportunity to experience Chanje's advanced vehicle technology on a short-term basis.
CSFL

Hot Stocks

07:08 EDT CenterState Banks announces two acquisitions - CenterState Banks announced the concurrent signing of two separate definitive merger agreements: under one agreement, CenterState will acquire HCBF Holding Company, the parent company of Harbor Community Bank, Ft. Pierce Florida; and under the other agreement, CenterState will acquire Sunshine Bancorp, the parent company of Sunshine Bank, Plant City, Florida. Upon completion of each merger, the subsidiary bank of each of Harbor and Sunshine will merge into CenterState Bank. Upon completion of both mergers, CenterState will become the largest community banking company in the state of Florida by assets, market capitalization, deposit market share and branch footprint. Based on June 30, 2017 results, including the impact of purchase accounting, the combined company is expected to have pro forma approximately $10.1 billion in assets, $6.6 billion in loans and $8.1 billion in deposits, and would expand and strengthen CenterState's presence in key Florida markets. The two transactions combined are expected to result in mid-single-digit EPS accretion and minimal tangible book value dilution, expected to be earned back in less than three years on a fully phased in basis, including the impact of CenterState crossing $10 billion in assets. Subject to the terms of the Harbor merger agreement, Harbor shareholders will receive 0.675 of a share of CSFL common stock and $1.925 in cash consideration for each outstanding share of Harbor common stock. Based on CSFL's stock price of $23.93 as of August 11, 2017, this equates to a per share value of $18.08 and an aggregate deal value of $416.7 million. Upon completion of the Harbor merger, Mike Brown, Sr., Chairman and CEO of Harbor, will join the CenterState board of directors. Subject to the terms of the Sunshine merger agreement, Sunshine shareholders will receive 0.89 shares of CSFL common stock for each outstanding share of Sunshine. Based on CSFL's stock price of $23.93 as of August 11, 2017, this equates to a per share value of $21.30 and an aggregate deal value of $176.7 million. Each of the Harbor and Sunshine merger agreements has been unanimously approved by the CenterState board of directors. The Harbor board of directors has unanimously approved the Harbor merger agreement, and the Sunshine board of directors has unanimously approved the Sunshine merger agreement. Each of the transactions is expected to close in the first quarter of 2018 and is not conditioned on the other.
LTS

Hot Stocks

07:07 EDT Compass Financial Resources joins Securities America - "Securities America, a wholly owned subsidiary of Ladenburg Thalmann Financial Services, is pleased to welcome Compass Financial Resources," the company said. The Olathe, Kansas-based firm has ten advisors and ten support staff members with $340M in client assets. It also has offices in Hutchinson, Kansas, and Lincoln, Nebraska.
BRO

Hot Stocks

07:06 EDT Brown & Brown announces asset acquisition of Shenkel Insurance Agency - Brown & Brown and Steven Shenkel, sole principal of Shenkel Insurance Agency, announced that Brown & Brown of Massachusetts, LLC, a subsidiary of Brown & Brown, Inc., has acquired substantially all of the assets of Shenkel Insurance. Following the transaction, Shenkel Insurance will combine with Brown & Brown's profit center in Dedham, Massachusetts, which operates under the direction of Mike Ross.
FRED

Hot Stocks

07:04 EDT Fred's names Alden Global President Heath Freeman to board - Fred's announced that it has appointed Heath Freeman, President and Founding Member of Alden Global Capital, to its Board of Directors, effective at its next scheduled meeting, which is expected to be held on or before August 29. Freeman is being added to the Fred's Board in connection with the execution of an Amended and Restated Cooperation Agreement between Alden and Fred's, dated August 11. The Amended and Restated Cooperation Agreement extends the term of the parties' agreement into 2019 and contains updated terms regarding the parties' collaborative efforts to maximize value for Fred's shareholders.
ULBI

Hot Stocks

07:04 EDT Ultralife awarded $4.7M communications system follow-on contract - Ultralife has been awarded a contract valued at approximately $4.7M to supply its Vehicle Installed Power Enhanced Rifleman Applique, or VIPER, to Thales Defense & Security. This contract follows VIPER awards received and shipped in 2015 and 2016 totaling $10.5M. Shipments are expected to commence in 2017 and be completed in the first half of 2018.
SPPI

Hot Stocks

07:04 EDT Spectrum announces initiation of registrational Phase 3 trial of Qapzola - Spectrum Pharmaceuticals announced the company has enrolled the first patient in a Phase 3 trial of Qapzola, a potent tumor-activated drug being investigated for low and intermediate risk non-muscle invasive bladder cancer. Under the SPA, this trial will evaluate the intravesical use of Qapzola in patients with non-muscle invasive bladder cancer, as a single instillation 60 +/- 30 minutes, following transurethral resection of the bladder tumor. "Qapzola is being developed for low-to-intermediate risk non-muscle invasive bladder cancer for which there are no approved drugs in the 21st century," said Rajesh Shrotriya, MD, chairman and CEO. "This is a novel drug that becomes cytotoxic only when it encounters hypoxic tumor such as non-muscle invasive bladder cancer. Bladder tumors are rich in DT-diaphorase, an enzyme that converts Qapzola into an alkylating agent that leads to cell death. One of the key challenges in the treatment of bladder cancer is a significantly high recurrence rate which leads to exorbitant costs and high patient morbidity. It is estimated that the cost of treatment of this disease will surpass $5B n by 2020. The design of the current trial incorporates learnings from previous studies, feedback from leading KOL's as well as from the FDA. I believe, Spectrum's pipeline has never been as exciting as it is today. In addition to aggressive development of Qapzola, we expect to file a registration application with the FDA for Rolontis in 2018 and we are very excited with the early data we are seeing with Poziotinib, our novel irreversible tyrosine kinase inhibitor." In accordance with the SPA, the Phase 3 trial is a randomized, double-blind, placebo-controlled, multi-center trial that will enroll patients with low and intermediate risk NMIBC as per the American Urology Association Guidelines. The new study design with a reduced sample size from 1557 to about 425 patients will significantly shorten the duration of this trial. The protocol includes a single instillation of Qapzola 60 +/- 30 minute post-TURBT, to avoid inactivation of Qapzola by blood that is present after surgery. The patients will be randomized 2:1 to receive either 8 mg instillation of Qapzola or placebo post-TURBT. Following one instillation of study drug and a safety follow-up at Day 35, subsequent follow up visits will be conducted until tumor recurrence or end of study, whichever occurs first. The primary endpoint for this trial is Time to Recurrence.
CVM

Hot Stocks

07:04 EDT CEL-SCI says FDA removes clinical hold on Phase 3 head and neck cancer trial - CEL-SCI announced it has received a letter from the U.S. FDA stating that the clinical hold that had been imposed on the company's Phase 3 cancer study with Multikine has been removed and that all clinical trial activities under this Investigational New Drug application may resume. Multikine is being studied as a potential first-line immunotherapy that is aimed at harnessing the patient's own immune system to produce an anti-tumor response. Nine hundred twenty-eight newly diagnosed head and neck cancer patients have been enrolled in this Phase 3 cancer study and all the patients who have completed treatment continue to be followed for protocol-specific outcomes in accordance with the Study Protocol. The study's primary endpoint is a 10% increase in overall survival for patients treated with the Multikine treatment regimen plus standard of care versus those who receive SOC only. The determination if the study's primary end point has been met will occur when there are a total of 298 deaths in those two groups. Current SOC for this indication is surgery, followed by radiation therapy alone or followed by concurrent radio-chemotherapy.

Hot Stocks

07:03 EDT Trump tweets about trade deals and 'Obstructionist Democrats' - President Donald Trump just tweeted, "The Obstructionist Democrats have given us (or not fixed) some of the worst trade deals in World History. I am changing that fast!."
ERN

Hot Stocks

07:03 EDT Erin Energy announces spud of Oyo-9 well - Erin Energy announced it has commenced drilling of the Oyo-9 well. Oyo-9 is being drilled with the Pacific Bora sixth-generation drilling rig on the Oyo field offshore Nigeria. The well is expected to take approximately 62 days to drill and complete. The tie-in of the well to the FPSO for production commencement is expected in the later part of the fourth-quarter 2017. The well is expected to add an additional 6,000 to 7,000 barrels of oil per day to the field's current production.
AXTA

Hot Stocks

07:02 EDT Axalta Coating to acquire Plascoat Systems; terms not disclosed - Axalta Coating Systems has acquired Plascoat Systems Limited, a supplier of thermoplastic powder coatings, from its parent company, International Process Technologies. Financial terms of the transaction were not disclosed.
BTX

Hot Stocks

07:01 EDT BioTime announces $2M grant for further development of OpRegen for Dry-AMD - BioTime, has been awarded a new grant for 2017 of up to 7.2 million Israeli New Shekels, or approximately $2M, from the Israel Innovation Authority. The grant provides funding for the continued development of OpRegen, and to date the IIA has provided annual grants totaling approximately $12M. OpRegen is currently in a Phase I/IIa dose-optimization clinical study, which in July 2017 received authorization from the Data Safety Monitoring Board to move forward with enrollment of cohort 3. In cohort 3, BioTime plans to treat patients at sites in Israel and the U.S. Data reported to date have shown continued engraftment through the one year follow-up with encouraging potential structural improvement. In addition, no serious adverse events have been reported, indicating a continued favorable safety profile. BioTime expects to share more data at the American Academy of Ophthalmology later this year.
MACK

Hot Stocks

07:00 EDT Merrimack appoints Jean Franchi as CFO - Merrimack Pharmaceuticals announced that it has strengthened its executive management team with the appointment of Jean Franchi as CFO, effective August 21. In this role, Franchi will plan and oversee Merrimack's financial strategy to support the ongoing development of multiple clinical- and preclinical-stage product candidates for cancer. Prior to joining Merrimack, Franchi most recently served as the CFO for Dimension Therapeutics, where she was responsible for all financial activities and related business strategy, including the company's initial public offering in 2015.
VFC

Hot Stocks

06:58 EDT VF Corp. raises FY17 outlook
VFC

Hot Stocks

06:57 EDT VF Corp. to acquire Williamson-Dickie Mfg. Co for about $820M in cash - VF Corporation and Williamson-Dickie Mfg. Co., a family-owned, private global workwear company, jointly announced that they have signed a definitive merger agreement. The transaction is expected to be completed early in the fourth quarter of this year and VF will pay Williamson-Dickie shareholders approximately $820M in cash. On a trailing 12-month basis, Williamson-Dickie generated approximately $875M of revenue.
VFC

Hot Stocks

06:56 EDT VF Corp. to acquire Williamson-Dickie Mfg. Co for about $820M in cash
SOL

Hot Stocks

06:51 EDT ReneSola, Nautilus Solar announce acquisition of 13.3MW solar portfolio - ReneSola and Nautilus Solar Energy jointly announced Nautilus's acquisition of an approximately 13.3 MW community solar portfolio previously developed by ReneSola. The community solar portfolio, qualified under Xcel Energy's burgeoning community solar program, is located in the rapidly expanding Minnesota solar marketplace. The portfolio is expected to be built through the remainder of 2017, coming online during Q1 2018. Now that Nautilus has finalized the transaction with ReneSola, the projects will be owned by an affiliate of Virgo Investment Group, which is also a minority shareholder of Nautilus Solar Energy. Nautilus, through its full-service platform, will provide development and long-term asset management services for the project. The energy provided by the portfolio directly benefits local community off-takers located offsite by lowering overall energy procurement costs while advancing renewable energy targets.
ZYNE

Hot Stocks

06:48 EDT Zynerba: results from Phase 2 STOP trial support continued development of ZYN002 - Zynerba Pharmaceuticals reported top line results from its Phase 2 STOP, or Synthetic Transdermal Cannabidiol for Treatment of Knee Pain due to Osteoarthritis, clinical trial evaluating ZYN002. The study did not meet its primary endpoint of reduction from baseline in the weekly mean of the 24-hour average worst pain score at week 12 for either dose. However, statistically significant results were achieved for a number of secondary endpoints. Importantly, the composite responder analysis for 250 mg daily of ZYN002 4.2% CBD gel achieved statistical significance. A trend toward statistical significance was observed in other secondary endpoints. "Many osteoarthritis patients using currently available medicines do not experience relief from pain and improved physical functioning, or cannot tolerate them due to side effects," said Daniel Clauw, M.D., Professor of Pain Management and Anesthesiology at the University of Michigan, and Director of the Chronic Pain and Fatigue Research Center. "The STOP trial results are encouraging and suggest that ZYN002 can play an important role in impacting the pain and impaired physical function associated with osteoarthritis, with a well-tolerated safety profile. I am particularly impressed with the composite analysis result which accounts for both pain and physical function. I believe that ZYN002 may provide a promising treatment option for OA, and I look forward to participating in future studies."
CSIQ

Hot Stocks

06:37 EDT Canadian Solar backs FY17 module shipments view of 6 GW-6.5 GW - Canadian Solar reiterates its expectation that total module shipments in 2017 will be in the range of 6.0 GW-6.5 GW. The module shipments recognized in revenue and total annual revenue will depend on market conditions, including ASP trends. The company continues to expect it will connect approximately 1 GW-1.2 GW of new solar projects globally in 2017, based on the commercial operation date, or COD. These projects are located in the U.S., Japan, China, the UK, India, Brazil and Africa. The revenue from the company's energy business will mainly come from the monetization of the company's high quality solar power plant assets in the U.S., Japan, China, UK, India and Brazil. Management expects that the increase in vertical integration along the manufacturing cycle will help the company maintain or improve its gross margin.
FLR

Hot Stocks

06:37 EDT Fluor announces agreement with Texas Central Rail Holdings - Fluor announced that an agreement was reached with Texas Central Rail Holdings to advance the preliminary development of the 240-mile high-speed passenger rail line connecting Dallas/Fort Worth and Houston. Fluor will support Texas Central during the preliminary development by refining the project's engineering, design-build cost estimate, schedule and construction planning, and potentially further phases of development. Under this agreement, after the development phase and financial close, Fluor and its partners would be the preferred design-builder of the project connecting North Texas and Houston.
AL...

Hot Stocks

06:36 EDT Air Lease announces lease placement Boeing 787 Dreamliner with Aeromexico - Air Lease (AL) announced a long term lease agreement with Aeromexico for one additional new Boeing (BA) 787-9 aircraft with General Electric (GE) engines. The aircraft is from ALC's order book with Boeing and will be Aeromexico's fourth new 787-9 lease from ALC. Two of the Dreamliner aircraft have already delivered to the airline, with the third scheduled to deliver in June 2018 and the fourth in April 2019.
OPHT

Hot Stocks

06:34 EDT Ophthotech: Third Phase 3 trial of Fovista did not meet primary endpoint - Ophthotech announced that the pre-specified primary endpoint of mean change in visual acuity at 12 months was not achieved in its Phase 3 clinical trial investigating the superiority of Fovista anti-PDGF therapy in combination with Eylea or Avastin anti-VEGF therapy compared to Eylea or Avastin monotherapy for the treatment of wet age-related macular degeneration. The addition of 1.5mg of Fovista to an Eylea or Avastin regimen did not result in benefit as measured by the mean change in visual acuity at the 12-month time point.
PLYM

Hot Stocks

06:30 EDT Plymouth Industrial REIT completes First UPREIT transaction - Plymouth Industrial REIT completed the previously announced acquisition of two Class B industrial properties in Indianapolis, Indiana for total consideration of $16.875 million. The purchase price includes approximately $8.8M in cash, which was funded from borrowings on the Company's new secured revolving credit facility, and the issuance of 425,150 units of Plymouth's Operating Partnership valued at $19.00 per share. The properties are projected to provide an initial yield of 8.5%.
MRVC

Hot Stocks

06:27 EDT ADVA Optical Networking completes tender offer for acquisition of MRV Communications - ADVA Optical Networking announced that a majority of the shares of MRV Communications were validly tendered and the other conditions to the tender offer have been satisfied. American Stock Transfer & Trust Company LLC, the depositary for the tender offer, has indicated that as of midnight EDT, Friday, August 11, 2017, a total of 5,296,053 shares of MRV Communications, Inc.'s common stock, or approximately 79% of the total number of shares issued and outstanding, have been validly tendered into and not properly withdrawn from the tender offer. The depositary has indicated that no shares were tendered pursuant to the guaranteed delivery procedures set forth in the Offer to Purchase. The acquisition of MRV Communications, Inc. will be consummated by ADVA Optical Networking on Monday, August 14, 2017. ADVA Optical Networking will consummate the acquisition of the remaining MRV Communications, Inc. shares of common stock not acquired in the tender offer through a merger pursuant to Section 251(h) of the General Corporation Law of the State of Delaware. As a result of such merger, MRV Communications, Inc. will become an indirect wholly-owned subsidiary of ADVA Optical Networking and MRV Communications shares will no longer be traded on the NASDAQ Stock Market.
AMRN

Hot Stocks

06:14 EDT Amarin: REDUCE-IT cardiovascular outcomes study to continue as planned - Amarin announced that, as expected, the independent data monitoring committee has completed its review of the scheduled pre-specified interim efficacy and safety analysis for the REDUCE-IT cardiovascular outcomes study and has recommended that the trial continue as planned without modification. Because REDUCE-IT is the first prospective clinical trial of any therapy in the large patient population studied, the bars for stopping this trial early for overwhelming efficacy were intentionally set high with the understanding that a more robust result, based on a larger number of cardiovascular events, could be obtained by the study continuing to completion. Results from the completed study are expected in Q2 or Q3 2018. The 8,175-patient outcomes study is evaluating whether treatment with Vascepa reduces major adverse cardiovascular events in patients who despite stabilized statin therapy have elevated triglyceride levels and other cardiovascular risk factors. In accordance with the study protocol, this interim efficacy analysis was performed after adjudication of approximately 80% of the target 1,612 aggregate primary cardiovascular events occurred within the study. Preparations for a final efficacy analysis will be triggered by the onset of approximately 100% of the target aggregate number of primary cardiovascular events. Amarin anticipates that the onset of approximately 100% of events will likely occur in early 2018. Amarin is intentionally blinded to the interim analysis data and will remain blinded to results of the study until after the study is stopped and the database is locked at the final analysis. The DMC's recommendation to continue as planned also reflects its review of all available safety data. In accordance with the study protocol and DMC charter, safety reviews have been performed multiple times each year since REDUCE-IT began in December 2011, and more than 30,000 patient years of study have been accumulated to date in the ongoing REDUCE-IT study. The review and recommendation of the DMC at this interim look were made independently. Neither Amarin nor the FDA has reviewed the interim clinical results and neither participated in the DMC's closed session deliberation.
ANDV...

Hot Stocks

06:10 EDT Andeavor to acquire Western Refining Logistics in $1.8B transaction - Andeavor (ANDV), Andeavor Logistics LP (ANDX) and Western Refining Logistics, LP (WNRL) announced the merger of Andeavor Logistics and Western Refining Logistics and the financial repositioning of Andeavor Logistics through a buy-in of Andeavor Logistics' incentive distribution rights. These transactions will generate approximately 93M newly issued ANDX common units to Andeavor, which will bring Andeavor's total ownership to approximately 127M units. Andeavor Logistics and WNRL jointly announced a definitive merger agreement whereby Andeavor Logistics will acquire WNRL in a unit-for-unit exchange at a blended exchange ratio of 0.4921, representing an equity value of $1.5B based on Andeavor Logistics closing unit price of $48.31 on August 11, 2017. This represents an enterprise value of $1.8 billion, including the assumption of approximately $310M of WNRL's net debt. The estimated 2018 EBITDA multiple is approximately 8.6x, excluding estimated 2018 GP/IDR distributions for WNRL of $22M. Andeavor and Andeavor Logistics also announced an agreement for Andeavor Logistics to issue, conditional upon the closing of the Merger, 78M ANDX common units to Andeavor in exchange for the cancellation of Andeavor Logistics' IDRs. The IDR Buy-In is expected to take place immediately after the Merger. These transactions have been approved by the boards of directors of all three companies as well as the conflicts committees of both MLPs. Upon closing, Greg Goff will continue to serve as Chairman and Chief Executive Officer and Steven Sterin as President and Chief Financial Officer of the general partner of Andeavor Logistics. The Merger transaction and IDR Buy-In is expected to close in the fourth quarter 2017 and the Merger is subject to customary closing conditions, including regulatory and approval from holders of a majority of the WNRL units.
HHS

Hot Stocks

06:10 EDT Harte-Hanks receives notice of non-compliance from NYSE - Harte Hanks announced that on August 9 it received notification from the New York Stock Exchange that the company is not in compliance with certain NYSE continued listing standards relating to average share price. The NYSE noted that as of August 7, the company's average closing price was less than the $1.00 minimum over a consecutive 30 trading-day period. The company has six months to cure the non-compliance by bringing its share price and average share price back above $1.00. In the event that after the six-month cure period, both a $1.00 share price and a minimum $1.00 30-day average share price are not attained the NYSE will commence suspension and delisting procedures. During the cure period, Harte Hanks common stock will continue to be listed on the NYSE. The company's common stock will continue to trade under the symbol "HHS," but will have an added symbol of ".BC" to indicate that the company is below compliance with the NYSE's listing standards.
SNGX

Hot Stocks

06:08 EDT Soligenix receives $2.5M in additional NIAID funding - Soligenix announced that the National Institute of Allergy and Infectious Diseases, or NIAID, part of the National Institutes of Health, or NIH, has exercised an option to fund good manufacturing practices, opr GMP, compliant RiVax bulk drug substance and finished drug product manufacturing, which is required for the conduct of future preclinical and clinical safety and efficacy studies. The overall objectives of the contract are to advance the development of Soligenix's thermostabilization technology, ThermoVax, in combination with the company's ricin toxin vaccine, RiVax, as a medical countermeasure to prevent the effects of ricin exposure. The exercised option for contract #HHSN272201400039C will provide Soligenix with approximately $2.5M in additional non-dilutive funding, bringing the total amount awarded to date under this contract to $21.2M. If all contract options are exercised, the total award of up to $24.7M will support the preclinical, manufacturing and clinical development activities necessary to advance heat stable RiVax with the FDA.
ANDV...

Hot Stocks

06:07 EDT Andeavor to acquire Western Refining Logistics in $1.8B transaction
SNAP

Hot Stocks

06:07 EDT Snap confirms acquisition of Zenly for $213.3M in cash - In a regulatory filing, Snap confirmed that in May, "We acquired Zenly SAS, a company that develops a location-based social media application that allows users to see where their friends are on a map. The purpose of the acquisition was to enhance the functionality of our platform. The total consideration paid was $213.3M in cash, of which $196.1M represents purchase consideration and includes $186.8M in cash paid to the sellers and $9.3M of liabilities due to the sellers. The remaining $17.2M of total consideration transferred represents compensation for future employment services. The allocation of purchase price is preliminary and is subject to additional information related to the liabilities that existed as of the acquisition date." Snap also confirmed that in July, it acquired an advertising measurement services company for $135.2M in cash. "The company was acquired to enhance advertising effectiveness. We are currently in the process of valuing the assets acquired and liabilities assumed in the transaction. Results of operations for the acquired company will be included in our consolidated financial statements from the date of acquisition." The Fly notes that Snap acquired Seattle-based Placed in July.
NBR TESO

Hot Stocks

06:06 EDT Nabors agrees to acquire Tesco in deal that values Tesco at $4.62 per share - Nabors Industries (NBR) announced that the company has signed an Arrangement Agreement to acquire all of the issued and outstanding common shares of Tesco (TESO), with each outstanding share of common stock of Tesco being exchanged for 0.68 common shares of Nabors. This transaction will create a leading rig equipment and drilling automation provider by combining Canrig, Nabors rig equipment subsidiary, with Tesco's rig equipment manufacturing, rental and aftermarket service business. Additionally, Tesco operates a tubular services business in numerous key regions globally, which will immediately benefit Nabors Drilling Solutions' operation. This transaction values Tesco common stock at $4.62 per share based on the closing price of Nabors shares on the NYSE on August 11, which represents a 19% premium of the closing value of Tesco shares on the NASDAQ Stock Market on August 11. The transaction is subject to regulatory approval and customary closing conditions and is expected to close in Q4. The transaction has been approved by the boards of directors of both companies and is subject to approval by Tesco shareholders and the satisfaction of customary closing conditions and regulatory approvals.
TESO NBR

Hot Stocks

06:03 EDT Tesco to combine with Nabors Industries in stock-for-stock transaction - Tesco Corporation (TESO) announced that it has entered in to an Arrangement Agreement with Nabors Industries (NBR) to combine with Nabors in a stock-for-stock transaction. TESCO shareholders will be issued 0.68 common shares of Nabors for each outstanding share of common stock of TESCO. Upon consummation of this transaction, TESCO shareholders will own approximately 10% of the outstanding shares of Nabors. The transaction has been approved by the board of directors of both companies and is subject to approval by TESCO security holders and satisfaction of customary closing conditions and regulatory approvals, including court approval required by Section 3(a)(10) of the Securities Act of 1933, as amended. This transaction values TESCO common stock at $4.62 per share based on Nabors closing share price of $6.80 on the New York Stock Exchange on August 11, 2017. This represents a premium of 19% to TESCO's closing price on the NASDAQ Stock Market on the same date, and represents a premium of 30% to TESCO's enterprise value based on TESCO's June 30, 2017 cash balance. Transaction expected to close in fourth quarter of 2017.
BK...

Hot Stocks

06:02 EDT Peltz's Trian buys more Pentair and Procter in Q2, sells Wendy's - Nelson Peltz's Trian Fund Management disclosed in an SEC filing Friday after the close its holdings as of June 30. Trian increased its stake in five holdings: BNY Mellon (BK), Pentair (PNR), Procter & Gamble (PG), Sysco (SYY) and General Electric (GE). The fund reduced its stake in two holdings: Mondelez (MDLZ) and Wendy's (WEN). Trian's top holdings as of June 30, in order of size, were Procter & Gamble, Sysco, GE, Mondelez and BNY Mellon.
TESO NBR

Hot Stocks

06:00 EDT Tesco to combine with Nabors Industries in stock-for-stock transaction
BLK...

Hot Stocks

05:52 EDT Loeb's Third Point makes BlackRock, Alibaba top holdings in Q2 - Dan Loeb's Third Point disclosed in an SEC filing Friday after the close its holdings as of June 30. Third Point made eight new buys during the second quarter, including, by order of size, BlackRock (BLK), Alibaba (BABA), NXP Semiconductors (NXPI), Vulcan Materials (VMC) and Alexion Pharmaceuticals (ALXN). Third Point exited 13 positions during the quarter, including by size of previous position, JPMorgan (JPM), Salesforce (CRM), Qualcomm (QCOM), Zayo Group (ZAYO) and Rice Energy (RICE). The fund increased its stake in 11 holdings, including by size, Alphabet Class A (GOOGL), Facebook (FB), Bank of America (BAC), Anthem (ANTM) and Parsley Energy (PE). Third Point reduced its stake in 8 holdings, including by size, Charter Communications (CHTR), Sherwin-Williams (SHW), Humana (HUM), Mohawk Industries (MHK) and Constellation Brands (STZ). Third Point's top holdings as of June 30, in order of size, were Baxter (BAX), Dow Chemical (DOW), BlackRock, Alibaba and Alphabet.
MASI

Hot Stocks

05:17 EDT Masimo announces DHA augmentation of current inventory of Masimo equipment - Masimo announced that the Dubai Health Authority, or DHA, the government organization that oversees the healthcare systems of Dubai, is augmenting its current inventory of Masimo equipment and technology with the implementation of Masimo Patient SafetyNet, a supplemental remote monitoring and clinician notification system, at two hospitals in Dubai.